Outcome or subgroup title,No. of studies,No. of participants,Statistical method,Effect size,comparison_name,comparison_id,effect_size,lower_ci,upper_ci,outcome_id,subgroup_id,outcome_name,subgroup_name
1.1 Service use ‐ readmission to hospital (combined time points) Show forest plot,9,1433,"Risk Ratio (IV, Random, 95% CI)","1.53 [0.84, 2.81]",Dose reduction versus dose maintenance,1,1.53,0.84,2.81,1,1,,Service use ‐ readmission to hospital (combined time points) Show forest plot
1.1.1 Combined time points,9,1433,"Risk Ratio (IV, Random, 95% CI)","1.53 [0.84, 2.81]",Dose reduction versus dose maintenance,1,1.53,0.84,2.81,1,1,,Combined time points
1.2 Service use ‐ readmission to hospital (separated time points) Show forest plot,9,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,2,,Service use ‐ readmission to hospital (separated time points) Show forest plot
1.2.1 < 3 months,3,583,"Risk Ratio (IV, Random, 95% CI)","3.05 [1.46, 6.34]",Dose reduction versus dose maintenance,1,3.05,1.46,6.34,1,2,,< 3 months
1.2.2 < 6 months,5,647,"Risk Ratio (IV, Random, 95% CI)","2.06 [0.88, 4.83]",Dose reduction versus dose maintenance,1,2.06,0.88,4.83,1,2,,< 6 months
1.2.3 < 1 year,3,573,"Risk Ratio (IV, Random, 95% CI)","1.46 [0.24, 9.05]",Dose reduction versus dose maintenance,1,1.46,0.24,9.05,1,2,,< 1 year
1.2.4 > 1 year,1,213,"Risk Ratio (IV, Random, 95% CI)","1.01 [0.64, 1.60]",Dose reduction versus dose maintenance,1,1.01,0.64,1.6,1,2,,> 1 year
1.3 Adverse effect ‐ leaving the study early due to adverse effects ‐ overall tolerability (combined time points) Show forest plot,10,1340,"Risk Ratio (IV, Random, 95% CI)","2.20 [1.39, 3.49]",Dose reduction versus dose maintenance,1,2.2,1.39,3.49,1,3,,Adverse effect ‐ leaving the study early due to adverse effects ‐ overall tolerability (combined time points) Show forest plot
1.3.1 Combined time points,10,1340,"Risk Ratio (IV, Random, 95% CI)","2.20 [1.39, 3.49]",Dose reduction versus dose maintenance,1,2.2,1.39,3.49,1,3,,Combined time points
1.4 Adverse effect ‐ leaving the study early due to adverse effects ‐ overall tolerability (separated time points) Show forest plot,10,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,4,,Adverse effect ‐ leaving the study early due to adverse effects ‐ overall tolerability (separated time points) Show forest plot
1.4.1 < 3 months,6,319,"Risk Ratio (IV, Random, 95% CI)","1.06 [0.12, 9.60]",Dose reduction versus dose maintenance,1,1.06,0.12,9.6,1,4,,< 3 months
1.4.2 < 6 months,8,882,"Risk Ratio (IV, Random, 95% CI)","1.86 [0.80, 4.33]",Dose reduction versus dose maintenance,1,1.86,0.8,4.33,1,4,,< 6 months
1.4.3 < 1 year,5,699,"Risk Ratio (IV, Random, 95% CI)","2.38 [1.39, 4.09]",Dose reduction versus dose maintenance,1,2.38,1.39,4.09,1,4,,< 1 year
1.4.4 > 1 year,1,131,"Risk Ratio (IV, Random, 95% CI)",Not estimable,Dose reduction versus dose maintenance,1,,,,1,4,,> 1 year
1.5 Quality of life ‐ mean change score EQ‐5D Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,5,,Quality of life ‐ mean change score EQ‐5D Show forest plot
1.5.1 < 1 year,1,61,"Mean Difference (IV, Random, 95% CI)","0.01 [‐0.06, 0.09]",Dose reduction versus dose maintenance,1,0.01,-0.06,0.09,1,5,,< 1 year
1.6 Quality of life ‐ mean change score S‐QoL Show forest plot,1,,"Mean Difference (IV, Fixed, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,6,,Quality of life ‐ mean change score S‐QoL Show forest plot
1.6.1 < 6 months,1,97,"Mean Difference (IV, Fixed, 95% CI)","‐2.60 [‐9.15, 3.95]",Dose reduction versus dose maintenance,1,-2.6,-9.15,3.95,1,6,,< 6 months
1.7 Quality of life ‐ mean endpoint WHOQOL‐BREF Show forest plot,1,,"Mean Difference (IV, Fixed, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,7,,Quality of life ‐ mean endpoint WHOQOL‐BREF Show forest plot
1.7.1 < 1 year,1,128,"Mean Difference (IV, Fixed, 95% CI)","‐0.20 [‐4.62, 4.22]",Dose reduction versus dose maintenance,1,-0.2,-4.62,4.22,1,7,,< 1 year
1.7.2 > 1 year,1,128,"Mean Difference (IV, Fixed, 95% CI)","0.90 [‐3.59, 5.39]",Dose reduction versus dose maintenance,1,0.9,-3.59,5.39,1,7,,> 1 year
1.8 Quality of life ‐ mean endpoint QLS (Heinrich) Show forest plot,1,,"Mean Difference (IV, Fixed, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,8,,Quality of life ‐ mean endpoint QLS (Heinrich) Show forest plot
1.8.1 < 1 year,1,50,"Mean Difference (IV, Fixed, 95% CI)","2.68 [‐8.42, 13.78]",Dose reduction versus dose maintenance,1,2.68,-8.42,13.78,1,8,,< 1 year
1.9 Quality of life ‐ mean change QLS total (Heinrich) Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,9,,Quality of life ‐ mean change QLS total (Heinrich) Show forest plot
1.9.1 < 6 months,1,364,"Mean Difference (IV, Random, 95% CI)","0.30 [‐2.95, 3.55]",Dose reduction versus dose maintenance,1,0.3,-2.95,3.55,1,9,,< 6 months
1.10 Quality of life ‐ mean endpoint SWNS Show forest plot,1,,"Mean Difference (IV, Fixed, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,10,,Quality of life ‐ mean endpoint SWNS Show forest plot
1.10.1 < 3 months,1,19,"Mean Difference (IV, Fixed, 95% CI)","‐6.03 [‐14.71, 2.65]",Dose reduction versus dose maintenance,1,-6.03,-14.71,2.65,1,10,,< 3 months
1.10.2 < 6 months,1,19,"Mean Difference (IV, Fixed, 95% CI)","0.44 [‐8.19, 9.07]",Dose reduction versus dose maintenance,1,0.44,-8.19,9.07,1,10,,< 6 months
1.11 Quality of life ‐ mean change SWNS Show forest plot,2,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,11,,Quality of life ‐ mean change SWNS Show forest plot
1.11.1 < 3 months,1,16,"Mean Difference (IV, Random, 95% CI)","‐3.12 [‐12.69, 6.44]",Dose reduction versus dose maintenance,1,-3.12,-12.69,6.44,1,11,,< 3 months
1.11.2 < 6 months,1,16,"Mean Difference (IV, Random, 95% CI)","2.25 [‐11.43, 15.93]",Dose reduction versus dose maintenance,1,2.25,-11.43,15.93,1,11,,< 6 months
1.11.3 < 1 year,1,61,"Mean Difference (IV, Random, 95% CI)","‐0.10 [‐4.58, 4.38]",Dose reduction versus dose maintenance,1,-0.1,-4.58,4.38,1,11,,< 1 year
1.12 Quality of life ‐ mean change/endpoint SWNS Show forest plot,2,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,12,,Quality of life ‐ mean change/endpoint SWNS Show forest plot
1.12.1 < 3 months,1,19,"Mean Difference (IV, Random, 95% CI)","‐6.03 [‐14.71, 2.65]",Dose reduction versus dose maintenance,1,-6.03,-14.71,2.65,1,12,,< 3 months
1.12.2 < 6 months,1,19,"Mean Difference (IV, Random, 95% CI)","0.44 [‐8.19, 9.07]",Dose reduction versus dose maintenance,1,0.44,-8.19,9.07,1,12,,< 6 months
1.12.3 < 1 year,1,61,"Mean Difference (IV, Random, 95% CI)","‐0.10 [‐4.58, 4.38]",Dose reduction versus dose maintenance,1,-0.1,-4.58,4.38,1,12,,< 1 year
1.13 Quality of life ‐ mean change/endpoint all available scales (combined time points) Show forest plot,6,719,"Std. Mean Difference (IV, Random, 95% CI)","‐0.01 [‐0.17, 0.15]",Dose reduction versus dose maintenance,1,-0.01,-0.17,0.15,1,13,,Quality of life ‐ mean change/endpoint all available scales (combined time points) Show forest plot
1.13.1 Quality of life ‐ combined scales and time points,6,719,"Std. Mean Difference (IV, Random, 95% CI)","‐0.01 [‐0.17, 0.15]",Dose reduction versus dose maintenance,1,-0.01,-0.17,0.15,1,13,,Quality of life ‐ combined scales and time points
1.14 Quality of life ‐ mean change/endpoint all available scales (separated time points) Show forest plot,6,,"Std. Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,14,,Quality of life ‐ mean change/endpoint all available scales (separated time points) Show forest plot
1.14.1 Quality of life ‐ combined scales (< 3 months),1,19,"Std. Mean Difference (IV, Random, 95% CI)","‐0.59 [‐1.52, 0.35]",Dose reduction versus dose maintenance,1,-0.59,-1.52,0.35,1,14,,Quality of life ‐ combined scales (< 3 months)
1.14.2 Quality of life ‐ combined scales (< 6 months),3,480,"Std. Mean Difference (IV, Random, 95% CI)","‐0.02 [‐0.23, 0.18]",Dose reduction versus dose maintenance,1,-0.02,-0.23,0.18,1,14,,Quality of life ‐ combined scales (< 6 months)
1.14.3 Quality of life ‐ combined scales (< 1 year),3,239,"Std. Mean Difference (IV, Random, 95% CI)","0.02 [‐0.24, 0.27]",Dose reduction versus dose maintenance,1,0.02,-0.24,0.27,1,14,,Quality of life ‐ combined scales (< 1 year)
1.14.4 Quality of life ‐ combined scales (> 1 year),1,128,"Std. Mean Difference (IV, Random, 95% CI)","0.07 [‐0.28, 0.42]",Dose reduction versus dose maintenance,1,0.07,-0.28,0.42,1,14,,Quality of life ‐ combined scales (> 1 year)
1.15 Functioning ‐ mean endpoint GSDS Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,15,,Functioning ‐ mean endpoint GSDS Show forest plot
1.15.1 < 1 year,1,128,"Mean Difference (IV, Random, 95% CI)","0.10 [‐1.32, 1.52]",Dose reduction versus dose maintenance,1,0.1,-1.32,1.52,1,15,,< 1 year
1.15.2 > 1 year,1,128,"Mean Difference (IV, Random, 95% CI)","‐0.60 [‐2.11, 0.91]",Dose reduction versus dose maintenance,1,-0.6,-2.11,0.91,1,15,,> 1 year
1.16 Functioning ‐ mean endpoint GAF Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,16,,Functioning ‐ mean endpoint GAF Show forest plot
1.16.1 < 1 year,1,35,"Mean Difference (IV, Random, 95% CI)","1.70 [‐6.13, 9.53]",Dose reduction versus dose maintenance,1,1.7,-6.13,9.53,1,16,,< 1 year
1.17 Functioning ‐ mean change GAF Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,17,,Functioning ‐ mean change GAF Show forest plot
1.17.1 < 1 year,1,35,"Mean Difference (IV, Random, 95% CI)","‐1.10 [‐2.51, 0.31]",Dose reduction versus dose maintenance,1,-1.1,-2.51,0.31,1,17,,< 1 year
1.18 Functioning ‐ mean change PSP Show forest plot,2,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,18,,Functioning ‐ mean change PSP Show forest plot
1.18.1 < 3 months,1,20,"Mean Difference (IV, Random, 95% CI)","4.49 [‐3.27, 12.25]",Dose reduction versus dose maintenance,1,4.49,-3.27,12.25,1,18,,< 3 months
1.18.2 < 6 months,1,20,"Mean Difference (IV, Random, 95% CI)","10.38 [‐0.52, 21.28]",Dose reduction versus dose maintenance,1,10.38,-0.52,21.28,1,18,,< 6 months
1.18.3 < 1 year,1,364,"Mean Difference (IV, Random, 95% CI)","2.47 [‐0.04, 4.98]",Dose reduction versus dose maintenance,1,2.47,-0.04,4.98,1,18,,< 1 year
1.19 Functioning ‐ mean endpoint PSP Show forest plot,2,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,19,,Functioning ‐ mean endpoint PSP Show forest plot
1.19.1 < 3 months,1,20,"Mean Difference (IV, Random, 95% CI)","‐3.03 [‐12.73, 6.67]",Dose reduction versus dose maintenance,1,-3.03,-12.73,6.67,1,19,,< 3 months
1.19.2 < 6 months,1,20,"Mean Difference (IV, Random, 95% CI)","2.85 [‐6.53, 12.23]",Dose reduction versus dose maintenance,1,2.85,-6.53,12.23,1,19,,< 6 months
1.19.3 < 1 year,1,364,"Mean Difference (IV, Random, 95% CI)","2.20 [‐1.23, 5.63]",Dose reduction versus dose maintenance,1,2.2,-1.23,5.63,1,19,,< 1 year
1.20 Functioning ‐ mean endpoint SCLoF Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,20,,Functioning ‐ mean endpoint SCLoF Show forest plot
1.20.1 < 6 months,1,50,"Mean Difference (IV, Random, 95% CI)","‐0.18 [‐4.06, 3.70]",Dose reduction versus dose maintenance,1,-0.18,-4.06,3.7,1,20,,< 6 months
1.20.2 < 12 months,1,50,"Mean Difference (IV, Random, 95% CI)","‐2.35 [‐6.23, 1.53]",Dose reduction versus dose maintenance,1,-2.35,-6.23,1.53,1,20,,< 12 months
1.21 Functioning ‐ mean change SF‐36 mental component summary Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,21,,Functioning ‐ mean change SF‐36 mental component summary Show forest plot
1.21.1 < 6 months,1,369,"Mean Difference (IV, Random, 95% CI)","‐0.61 [‐3.07, 1.85]",Dose reduction versus dose maintenance,1,-0.61,-3.07,1.85,1,21,,< 6 months
1.22 Functioning ‐ mean endpoint/change all available scales (combined time points) Show forest plot,6,966,"Std. Mean Difference (IV, Random, 95% CI)","0.03 [‐0.10, 0.17]",Dose reduction versus dose maintenance,1,0.03,-0.1,0.17,1,22,,Functioning ‐ mean endpoint/change all available scales (combined time points) Show forest plot
1.22.1 Functioning ‐ combined scales and time points,6,966,"Std. Mean Difference (IV, Random, 95% CI)","0.03 [‐0.10, 0.17]",Dose reduction versus dose maintenance,1,0.03,-0.1,0.17,1,22,,Functioning ‐ combined scales and time points
1.23 Functioning ‐ mean endpoint/change all available scales (separated time points) Show forest plot,6,,"Std. Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,23,,Functioning ‐ mean endpoint/change all available scales (separated time points) Show forest plot
1.23.1 Functioning ‐ combined scales (< 3 months),1,20,"Std. Mean Difference (IV, Random, 95% CI)","‐0.25 [‐1.14, 0.63]",Dose reduction versus dose maintenance,1,-0.25,-1.14,0.63,1,23,,Functioning ‐ combined scales (< 3 months)
1.23.2 Functioning ‐ combined scales (< 6 months),3,439,"Std. Mean Difference (IV, Random, 95% CI)","‐0.04 [‐0.25, 0.17]",Dose reduction versus dose maintenance,1,-0.04,-0.25,0.17,1,23,,Functioning ‐ combined scales (< 6 months)
1.23.3 Functioning ‐ combined scales (< 1 year),4,577,"Std. Mean Difference (IV, Random, 95% CI)","0.08 [‐0.09, 0.25]",Dose reduction versus dose maintenance,1,0.08,-0.09,0.25,1,23,,Functioning ‐ combined scales (< 1 year)
1.23.4 Functioning ‐ combined scales (> 1 year),1,128,"Std. Mean Difference (IV, Random, 95% CI)","‐0.14 [‐0.48, 0.21]",Dose reduction versus dose maintenance,1,-0.14,-0.48,0.21,1,23,,Functioning ‐ combined scales (> 1 year)
1.24 Global state ‐ number of participants with relapse/exacerbations of psychosis (combined time points) Show forest plot,20,2481,"Risk Ratio (IV, Random, 95% CI)","2.16 [1.52, 3.06]",Dose reduction versus dose maintenance,1,2.16,1.52,3.06,1,24,,Global state ‐ number of participants with relapse/exacerbations of psychosis (combined time points) Show forest plot
1.25 Global state ‐ number of participants with relapse/exacerbations of psychosis (separated time points) Show forest plot,20,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,25,,Global state ‐ number of participants with relapse/exacerbations of psychosis (separated time points) Show forest plot
1.25.1 < 3 months,12,1947,"Risk Ratio (IV, Random, 95% CI)","2.56 [1.37, 4.78]",Dose reduction versus dose maintenance,1,2.56,1.37,4.78,1,25,,< 3 months
1.25.2 < 6 months,15,2224,"Risk Ratio (IV, Random, 95% CI)","2.37 [1.54, 3.67]",Dose reduction versus dose maintenance,1,2.37,1.54,3.67,1,25,,< 6 months
1.25.3 < 1 year,13,1608,"Risk Ratio (IV, Random, 95% CI)","2.31 [1.63, 3.27]",Dose reduction versus dose maintenance,1,2.31,1.63,3.27,1,25,,< 1 year
1.25.4 > 1 year,4,474,"Risk Ratio (IV, Random, 95% CI)","1.68 [1.29, 2.20]",Dose reduction versus dose maintenance,1,1.68,1.29,2.2,1,25,,> 1 year
1.26 Global state ‐ remission Show forest plot,1,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,26,,Global state ‐ remission Show forest plot
1.26.1 < 1 year,1,397,"Risk Ratio (IV, Random, 95% CI)","0.82 [0.61, 1.09]",Dose reduction versus dose maintenance,1,0.82,0.61,1.09,1,26,,< 1 year
1.27 Global state ‐ number of participants with clinically important change in global state Show forest plot,1,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,27,,Global state ‐ number of participants with clinically important change in global state Show forest plot
1.27.1 < 3 months,1,20,"Risk Ratio (IV, Random, 95% CI)","4.17 [0.23, 77.11]",Dose reduction versus dose maintenance,1,4.17,0.23,77.11,1,27,,< 3 months
1.27.2 < 6 months,1,20,"Risk Ratio (IV, Random, 95% CI)","4.17 [0.23, 77.11]",Dose reduction versus dose maintenance,1,4.17,0.23,77.11,1,27,,< 6 months
1.28 Global state ‐ mean endpoint CGI‐S (high = poor) Show forest plot,2,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,28,,Global state ‐ mean endpoint CGI‐S (high = poor) Show forest plot
1.28.1 < 3 months,2,46,"Mean Difference (IV, Random, 95% CI)","‐0.39 [‐0.86, 0.07]",Dose reduction versus dose maintenance,1,-0.39,-0.86,0.07,1,28,,< 3 months
1.28.2 < 6 months,2,46,"Mean Difference (IV, Random, 95% CI)","‐0.35 [‐0.84, 0.14]",Dose reduction versus dose maintenance,1,-0.35,-0.84,0.14,1,28,,< 6 months
1.29 Global state ‐ mean change CGI‐S (high = poor) Show forest plot,5,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,29,,Global state ‐ mean change CGI‐S (high = poor) Show forest plot
1.29.1 < 3 months,2,485,"Mean Difference (IV, Random, 95% CI)","0.10 [‐0.33, 0.53]",Dose reduction versus dose maintenance,1,0.1,-0.33,0.53,1,29,,< 3 months
1.29.2 < 6 months,2,485,"Mean Difference (IV, Random, 95% CI)","0.20 [‐0.34, 0.74]",Dose reduction versus dose maintenance,1,0.2,-0.34,0.74,1,29,,< 6 months
1.29.3 < 1 year,3,488,"Mean Difference (IV, Random, 95% CI)","0.03 [‐0.21, 0.27]",Dose reduction versus dose maintenance,1,0.03,-0.21,0.27,1,29,,< 1 year
1.30 Global state ‐ mean endpoint/change CGI‐S (high = poor) (combined time points) Show forest plot,6,999,"Mean Difference (IV, Random, 95% CI)","0.05 [‐0.18, 0.28]",Dose reduction versus dose maintenance,1,0.05,-0.18,0.28,1,30,,Global state ‐ mean endpoint/change CGI‐S (high = poor) (combined time points) Show forest plot
1.31 Global state ‐ mean endpoint/change CGI‐S (high = poor) (separated time points) Show forest plot,6,,"Std. Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,31,,Global state ‐ mean endpoint/change CGI‐S (high = poor) (separated time points) Show forest plot
1.31.1 < 3 months,3,511,"Std. Mean Difference (IV, Random, 95% CI)","‐0.11 [‐0.75, 0.52]",Dose reduction versus dose maintenance,1,-0.11,-0.75,0.52,1,31,,< 3 months
1.31.2 < 6 months,3,511,"Std. Mean Difference (IV, Random, 95% CI)","‐0.02 [‐0.71, 0.66]",Dose reduction versus dose maintenance,1,-0.02,-0.71,0.66,1,31,,< 6 months
1.31.3 < 1 year,3,488,"Std. Mean Difference (IV, Random, 95% CI)","0.04 [‐0.30, 0.37]",Dose reduction versus dose maintenance,1,0.04,-0.3,0.37,1,31,,< 1 year
1.32 Global state ‐ mean endpoint CGI‐I (high = poor) (combined time points) Show forest plot,3,881,"Mean Difference (IV, Random, 95% CI)","0.19 [‐0.47, 0.85]",Dose reduction versus dose maintenance,1,0.19,-0.47,0.85,1,32,,Global state ‐ mean endpoint CGI‐I (high = poor) (combined time points) Show forest plot
1.33 Global state ‐ mean endpoint CGI‐I (high = poor) (separated time points) Show forest plot,3,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,33,,Global state ‐ mean endpoint CGI‐I (high = poor) (separated time points) Show forest plot
1.33.1 < 3 months,2,484,"Mean Difference (IV, Random, 95% CI)","0.07 [‐1.07, 1.20]",Dose reduction versus dose maintenance,1,0.07,-1.07,1.2,1,33,,< 3 months
1.33.2 < 6 months,2,484,"Mean Difference (IV, Random, 95% CI)","‐0.04 [‐1.75, 1.68]",Dose reduction versus dose maintenance,1,-0.04,-1.75,1.68,1,33,,< 6 months
1.33.3 < 1 year,1,397,"Mean Difference (IV, Random, 95% CI)","0.36 [0.09, 0.63]",Dose reduction versus dose maintenance,1,0.36,0.09,0.63,1,33,,< 1 year
1.34 Global state ‐ mean change IAQ‐12 (high = poor) Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,34,,Global state ‐ mean change IAQ‐12 (high = poor) Show forest plot
1.34.1 < 1 year,1,397,"Mean Difference (IV, Random, 95% CI)","1.69 [0.47, 2.91]",Dose reduction versus dose maintenance,1,1.69,0.47,2.91,1,34,,< 1 year
1.35 Global state ‐ mean endpoint SCL‐90 (high = poor) Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,35,,Global state ‐ mean endpoint SCL‐90 (high = poor) Show forest plot
1.35.1 < 3 months,1,39,"Mean Difference (IV, Random, 95% CI)","‐0.38 [‐0.61, ‐0.15]",Dose reduction versus dose maintenance,1,-0.38,-0.61,-0.15,1,35,,< 3 months
1.35.2 < 6 months,1,39,"Mean Difference (IV, Random, 95% CI)","‐0.52 [‐0.80, ‐0.24]",Dose reduction versus dose maintenance,1,-0.52,-0.8,-0.24,1,35,,< 6 months
1.35.3 < 1 year,1,39,"Mean Difference (IV, Random, 95% CI)","‐0.59 [‐0.91, ‐0.27]",Dose reduction versus dose maintenance,1,-0.59,-0.91,-0.27,1,35,,< 1 year
1.36 Leaving the study early ‐ for any reason ‐ overall acceptability (combined time points) Show forest plot,12,1551,"Risk Ratio (IV, Random, 95% CI)","1.38 [1.05, 1.81]",Dose reduction versus dose maintenance,1,1.38,1.05,1.81,1,36,,Leaving the study early ‐ for any reason ‐ overall acceptability (combined time points) Show forest plot
1.36.1 Combined time points,12,1551,"Risk Ratio (IV, Random, 95% CI)","1.38 [1.05, 1.81]",Dose reduction versus dose maintenance,1,1.38,1.05,1.81,1,36,,Combined time points
1.37 Leaving the study early ‐ for any reason ‐ overall acceptability (separated time points) Show forest plot,12,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,37,,Leaving the study early ‐ for any reason ‐ overall acceptability (separated time points) Show forest plot
1.37.1 < 3 months,6,1067,"Risk Ratio (IV, Random, 95% CI)","1.53 [1.01, 2.31]",Dose reduction versus dose maintenance,1,1.53,1.01,2.31,1,37,,< 3 months
1.37.2 < 6 months,6,767,"Risk Ratio (IV, Random, 95% CI)","1.76 [1.27, 2.44]",Dose reduction versus dose maintenance,1,1.76,1.27,2.44,1,37,,< 6 months
1.37.3 < 1 year,7,814,"Risk Ratio (IV, Random, 95% CI)","1.47 [1.23, 1.76]",Dose reduction versus dose maintenance,1,1.47,1.23,1.76,1,37,,< 1 year
1.37.4 > 1 year,2,201,"Risk Ratio (IV, Random, 95% CI)","1.68 [0.19, 14.76]",Dose reduction versus dose maintenance,1,1.68,0.19,14.76,1,37,,> 1 year
1.38 Leaving the study early ‐ due to inefficacy ‐ overall efficacy (combined time points) Show forest plot,10,1322,"Risk Ratio (IV, Random, 95% CI)","2.06 [1.21, 3.50]",Dose reduction versus dose maintenance,1,2.06,1.21,3.5,1,38,,Leaving the study early ‐ due to inefficacy ‐ overall efficacy (combined time points) Show forest plot
1.39 Leaving the study early ‐ due to inefficacy ‐ overall efficacy (separated time points) Show forest plot,10,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,39,,Leaving the study early ‐ due to inefficacy ‐ overall efficacy (separated time points) Show forest plot
1.39.1 < 3 months,5,288,"Risk Ratio (IV, Random, 95% CI)","0.94 [0.28, 3.12]",Dose reduction versus dose maintenance,1,0.94,0.28,3.12,1,39,,< 3 months
1.39.2 < 6 months,5,687,"Risk Ratio (IV, Random, 95% CI)","3.48 [2.29, 5.30]",Dose reduction versus dose maintenance,1,3.48,2.29,5.3,1,39,,< 6 months
1.39.3 < 1 year,5,699,"Risk Ratio (IV, Random, 95% CI)","1.78 [0.68, 4.66]",Dose reduction versus dose maintenance,1,1.78,0.68,4.66,1,39,,< 1 year
1.39.4 > 1 year,1,131,"Risk Ratio (IV, Random, 95% CI)",Not estimable,Dose reduction versus dose maintenance,1,,,,1,39,,> 1 year
1.40 Mental state ‐ general: number of participants with clinically important change in general mental state (combined time points) Show forest plot,2,417,"Risk Ratio (IV, Random, 95% CI)","0.84 [0.75, 0.94]",Dose reduction versus dose maintenance,1,0.84,0.75,0.94,1,40,,Mental state ‐ general: number of participants with clinically important change in general mental state (combined time points) Show forest plot
1.40.1 < 1 year,2,417,"Risk Ratio (IV, Random, 95% CI)","0.84 [0.75, 0.94]",Dose reduction versus dose maintenance,1,0.84,0.75,0.94,1,40,,< 1 year
1.41 Mental state ‐ general: number of participants with clinically important change in general mental state (separated time points) Show forest plot,2,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,41,,Mental state ‐ general: number of participants with clinically important change in general mental state (separated time points) Show forest plot
1.41.1 < 3 months,1,20,"Risk Ratio (IV, Random, 95% CI)","2.50 [0.11, 54.87]",Dose reduction versus dose maintenance,1,2.5,0.11,54.87,1,41,,< 3 months
1.41.2 < 6 months,1,20,"Risk Ratio (IV, Random, 95% CI)","2.50 [0.11, 54.87]",Dose reduction versus dose maintenance,1,2.5,0.11,54.87,1,41,,< 6 months
1.41.3 < 1 year,1,397,"Risk Ratio (IV, Random, 95% CI)","0.84 [0.75, 0.94]",Dose reduction versus dose maintenance,1,0.84,0.75,0.94,1,41,,< 1 year
1.42 Mental state ‐ general: mean endpoint BPRS total (high = poor) Show forest plot,2,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,42,,Mental state ‐ general: mean endpoint BPRS total (high = poor) Show forest plot
1.42.1 < 3 months,1,26,"Mean Difference (IV, Random, 95% CI)","0.80 [‐2.93, 4.53]",Dose reduction versus dose maintenance,1,0.8,-2.93,4.53,1,42,,< 3 months
1.42.2 < 6 months,2,76,"Mean Difference (IV, Random, 95% CI)","‐0.63 [‐3.82, 2.55]",Dose reduction versus dose maintenance,1,-0.63,-3.82,2.55,1,42,,< 6 months
1.42.3 < 1 year,1,50,"Mean Difference (IV, Random, 95% CI)","‐0.60 [‐4.48, 3.28]",Dose reduction versus dose maintenance,1,-0.6,-4.48,3.28,1,42,,< 1 year
1.43 Mental state ‐ general: mean change BPRS total (high = poor) Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,43,,Mental state ‐ general: mean change BPRS total (high = poor) Show forest plot
1.43.1 < 3 months,1,466,"Mean Difference (IV, Random, 95% CI)","4.03 [2.11, 5.95]",Dose reduction versus dose maintenance,1,4.03,2.11,5.95,1,43,,< 3 months
1.43.2 < 6 months,1,466,"Mean Difference (IV, Random, 95% CI)","5.70 [3.59, 7.81]",Dose reduction versus dose maintenance,1,5.7,3.59,7.81,1,43,,< 6 months
1.44 Mental state ‐ general: mean endpoint PANSS total (high = poor) Show forest plot,7,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,44,,Mental state ‐ general: mean endpoint PANSS total (high = poor) Show forest plot
1.44.1 < 3 months,4,901,"Mean Difference (IV, Random, 95% CI)","2.37 [‐2.90, 7.65]",Dose reduction versus dose maintenance,1,2.37,-2.9,7.65,1,44,,< 3 months
1.44.2 < 6 months,4,901,"Mean Difference (IV, Random, 95% CI)","1.38 [‐6.66, 9.42]",Dose reduction versus dose maintenance,1,1.38,-6.66,9.42,1,44,,< 6 months
1.44.3 < 1 year,5,975,"Mean Difference (IV, Random, 95% CI)","‐1.25 [‐5.44, 2.93]",Dose reduction versus dose maintenance,1,-1.25,-5.44,2.93,1,44,,< 1 year
1.44.4 > 1 year,1,128,"Mean Difference (IV, Random, 95% CI)","‐1.20 [‐4.64, 2.24]",Dose reduction versus dose maintenance,1,-1.2,-4.64,2.24,1,44,,> 1 year
1.45 Mental state ‐ general: mean change PANSS total (high = poor) Show forest plot,8,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,45,,Mental state ‐ general: mean change PANSS total (high = poor) Show forest plot
1.45.1 < 3 months,4,906,"Mean Difference (IV, Random, 95% CI)","‐0.21 [‐6.17, 5.75]",Dose reduction versus dose maintenance,1,-0.21,-6.17,5.75,1,45,,< 3 months
1.45.2 < 6 months,4,980,"Mean Difference (IV, Random, 95% CI)","2.50 [‐3.46, 8.46]",Dose reduction versus dose maintenance,1,2.5,-3.46,8.46,1,45,,< 6 months
1.45.3 < 1 year,4,833,"Mean Difference (IV, Random, 95% CI)","1.94 [‐0.15, 4.02]",Dose reduction versus dose maintenance,1,1.94,-0.15,4.02,1,45,,< 1 year
1.46 Mental state ‐ general: mean endpoint/change overall symptom scales (PANSS/BPRS) (high = poor) (combined time points) Show forest plot,12,1718,"Std. Mean Difference (IV, Random, 95% CI)","0.02 [‐0.24, 0.27]",Dose reduction versus dose maintenance,1,0.02,-0.24,0.27,1,46,,Mental state ‐ general: mean endpoint/change overall symptom scales (PANSS/BPRS) (high = poor) (combined time points) Show forest plot
1.47 Mental state ‐ general: mean endpoint/change overall symptom scales (PANSS/BPRS) (high = poor) (separated time points) Show forest plot,12,,"Std. Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,47,,Mental state ‐ general: mean endpoint/change overall symptom scales (PANSS/BPRS) (high = poor) (separated time points) Show forest plot
1.47.1 < 3 months,7,1347,"Std. Mean Difference (IV, Random, 95% CI)","0.14 [‐0.11, 0.40]",Dose reduction versus dose maintenance,1,0.14,-0.11,0.4,1,47,,< 3 months
1.47.2 < 6 months,8,1471,"Std. Mean Difference (IV, Random, 95% CI)","0.06 [‐0.24, 0.37]",Dose reduction versus dose maintenance,1,0.06,-0.24,0.37,1,47,,< 6 months
1.47.3 < 1 year,7,1086,"Std. Mean Difference (IV, Random, 95% CI)","‐0.06 [‐0.36, 0.24]",Dose reduction versus dose maintenance,1,-0.06,-0.36,0.24,1,47,,< 1 year
1.47.4 > 1 year,1,128,"Std. Mean Difference (IV, Random, 95% CI)","‐0.12 [‐0.47, 0.23]",Dose reduction versus dose maintenance,1,-0.12,-0.47,0.23,1,47,,> 1 year
1.48 Mental state ‐ specific: mean endpoint PANSS positive (high = poor) Show forest plot,5,,"Std. Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,48,,Mental state ‐ specific: mean endpoint PANSS positive (high = poor) Show forest plot
1.48.1 < 3 months,2,95,"Std. Mean Difference (IV, Random, 95% CI)","‐0.27 [‐0.86, 0.33]",Dose reduction versus dose maintenance,1,-0.27,-0.86,0.33,1,48,,< 3 months
1.48.2 < 6 months,2,95,"Std. Mean Difference (IV, Random, 95% CI)","‐0.23 [‐0.64, 0.17]",Dose reduction versus dose maintenance,1,-0.23,-0.64,0.17,1,48,,< 6 months
1.48.3 < 1 year,4,635,"Std. Mean Difference (IV, Random, 95% CI)","‐0.10 [‐0.26, 0.06]",Dose reduction versus dose maintenance,1,-0.1,-0.26,0.06,1,48,,< 1 year
1.48.4 > 1 year,1,128,"Std. Mean Difference (IV, Random, 95% CI)","0.05 [‐0.30, 0.40]",Dose reduction versus dose maintenance,1,0.05,-0.3,0.4,1,48,,> 1 year
1.49 Mental state ‐ specific: mean change PANSS positive (high = poor) Show forest plot,8,,"Std. Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,49,,Mental state ‐ specific: mean change PANSS positive (high = poor) Show forest plot
1.49.1 < 3 months,3,509,"Std. Mean Difference (IV, Random, 95% CI)","0.02 [‐0.70, 0.74]",Dose reduction versus dose maintenance,1,0.02,-0.7,0.74,1,49,,< 3 months
1.49.2 < 6 months,3,583,"Std. Mean Difference (IV, Random, 95% CI)","0.27 [‐0.32, 0.86]",Dose reduction versus dose maintenance,1,0.27,-0.32,0.86,1,49,,< 6 months
1.49.3 < 1 year,4,833,"Std. Mean Difference (IV, Random, 95% CI)","0.24 [0.10, 0.39]",Dose reduction versus dose maintenance,1,0.24,0.1,0.39,1,49,,< 1 year
1.50 Mental state ‐ specific: mean endpoint/change positive symptoms (PANSS positive) (high = poor) (combined time points) Show forest plot,10,1337,"Std. Mean Difference (IV, Random, 95% CI)","0.07 [‐0.22, 0.35]",Dose reduction versus dose maintenance,1,0.07,-0.22,0.35,1,50,,Mental state ‐ specific: mean endpoint/change positive symptoms (PANSS positive) (high = poor) (combined time points) Show forest plot
1.51 Mental state ‐ specific: mean endpoint/change positive symptoms (PANSS positive) (high = poor) (separated time points) Show forest plot,10,,"Std. Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,51,,Mental state ‐ specific: mean endpoint/change positive symptoms (PANSS positive) (high = poor) (separated time points) Show forest plot
1.51.1 < 3 months,4,584,"Std. Mean Difference (IV, Random, 95% CI)","0.01 [‐0.51, 0.53]",Dose reduction versus dose maintenance,1,0.01,-0.51,0.53,1,51,,< 3 months
1.51.2 < 6 months,4,658,"Std. Mean Difference (IV, Random, 95% CI)","0.10 [‐0.45, 0.66]",Dose reduction versus dose maintenance,1,0.1,-0.45,0.66,1,51,,< 6 months
1.51.3 < 1 year,6,731,"Std. Mean Difference (IV, Random, 95% CI)","‐0.05 [‐0.20, 0.10]",Dose reduction versus dose maintenance,1,-0.05,-0.2,0.1,1,51,,< 1 year
1.51.4 > 1 year,1,128,"Std. Mean Difference (IV, Random, 95% CI)","0.05 [‐0.30, 0.40]",Dose reduction versus dose maintenance,1,0.05,-0.3,0.4,1,51,,> 1 year
1.52 Mental state ‐ specific: mean endpoint PANSS negative (high = poor) Show forest plot,5,,"Std. Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,52,,Mental state ‐ specific: mean endpoint PANSS negative (high = poor) Show forest plot
1.52.1 < 3 months,2,95,"Std. Mean Difference (IV, Random, 95% CI)","‐0.35 [‐0.75, 0.06]",Dose reduction versus dose maintenance,1,-0.35,-0.75,0.06,1,52,,< 3 months
1.52.2 < 6 months,2,95,"Std. Mean Difference (IV, Random, 95% CI)","‐0.92 [‐1.70, ‐0.13]",Dose reduction versus dose maintenance,1,-0.92,-1.7,-0.13,1,52,,< 6 months
1.52.3 < 1 year,4,635,"Std. Mean Difference (IV, Random, 95% CI)","‐0.26 [‐0.74, 0.22]",Dose reduction versus dose maintenance,1,-0.26,-0.74,0.22,1,52,,< 1 year
1.52.4 > 1 year,1,128,"Std. Mean Difference (IV, Random, 95% CI)","‐0.21 [‐0.56, 0.14]",Dose reduction versus dose maintenance,1,-0.21,-0.56,0.14,1,52,,> 1 year
1.53 Mental state ‐ specific: mean change PANSS negative (high = poor) Show forest plot,8,,"Std. Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,53,,Mental state ‐ specific: mean change PANSS negative (high = poor) Show forest plot
1.53.1 < 3 months,3,509,"Std. Mean Difference (IV, Random, 95% CI)","‐0.35 [‐1.26, 0.57]",Dose reduction versus dose maintenance,1,-0.35,-1.26,0.57,1,53,,< 3 months
1.53.2 < 6 months,3,583,"Std. Mean Difference (IV, Random, 95% CI)","0.05 [‐0.45, 0.54]",Dose reduction versus dose maintenance,1,0.05,-0.45,0.54,1,53,,< 6 months
1.53.3 < 1 year,4,833,"Std. Mean Difference (IV, Random, 95% CI)","‐0.06 [‐0.32, 0.21]",Dose reduction versus dose maintenance,1,-0.06,-0.32,0.21,1,53,,< 1 year
1.54 Mental state ‐ specific: mean endpoint/change negative symptoms (PANSS negative) (high = poor) (combined time points) Show forest plot,9,1302,"Std. Mean Difference (IV, Random, 95% CI)","‐0.19 [‐0.49, 0.12]",Dose reduction versus dose maintenance,1,-0.19,-0.49,0.12,1,54,,Mental state ‐ specific: mean endpoint/change negative symptoms (PANSS negative) (high = poor) (combined time points) Show forest plot
1.55 Mental state ‐ specific: mean endpoint/change negative symptoms (PANSS negative) (high = poor) (separated time points) Show forest plot,9,,"Std. Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,55,,Mental state ‐ specific: mean endpoint/change negative symptoms (PANSS negative) (high = poor) (separated time points) Show forest plot
1.55.1 < 3 months,4,584,"Std. Mean Difference (IV, Random, 95% CI)","‐0.15 [‐0.64, 0.34]",Dose reduction versus dose maintenance,1,-0.15,-0.64,0.34,1,55,,< 3 months
1.55.2 < 6 months,4,658,"Std. Mean Difference (IV, Random, 95% CI)","‐0.29 [‐1.04, 0.45]",Dose reduction versus dose maintenance,1,-0.29,-1.04,0.45,1,55,,< 6 months
1.55.3 < 1 year,5,696,"Std. Mean Difference (IV, Random, 95% CI)","‐0.31 [‐0.71, 0.10]",Dose reduction versus dose maintenance,1,-0.31,-0.71,0.1,1,55,,< 1 year
1.55.4 > 1 year,1,128,"Std. Mean Difference (IV, Random, 95% CI)","‐0.21 [‐0.56, 0.14]",Dose reduction versus dose maintenance,1,-0.21,-0.56,0.14,1,55,,> 1 year
1.56 Mental state ‐ specific: mean endpoint NSA‐16 (high = poor) Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,56,,Mental state ‐ specific: mean endpoint NSA‐16 (high = poor) Show forest plot
1.56.1 < 3 months,1,75,"Mean Difference (IV, Random, 95% CI)","‐4.80 [‐9.72, 0.12]",Dose reduction versus dose maintenance,1,-4.8,-9.72,0.12,1,56,,< 3 months
1.56.2 < 6 months,1,75,"Mean Difference (IV, Random, 95% CI)","‐6.60 [‐12.38, ‐0.82]",Dose reduction versus dose maintenance,1,-6.6,-12.38,-0.82,1,56,,< 6 months
1.56.3 < 1 year,1,75,"Mean Difference (IV, Random, 95% CI)","‐10.10 [‐14.87, ‐5.33]",Dose reduction versus dose maintenance,1,-10.1,-14.87,-5.33,1,56,,< 1 year
1.57 Mental state ‐ specific: mean change CDSS (high = poor) Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,57,,Mental state ‐ specific: mean change CDSS (high = poor) Show forest plot
1.57.1 < 1 year,1,61,"Mean Difference (IV, Random, 95% CI)","‐0.40 [‐1.55, 0.75]",Dose reduction versus dose maintenance,1,-0.4,-1.55,0.75,1,57,,< 1 year
1.58 Mental state ‐ specific: mean endpoint PANSS depression/anxiety (high = poor) Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,58,,Mental state ‐ specific: mean endpoint PANSS depression/anxiety (high = poor) Show forest plot
1.58.1 < 3 months,1,20,"Mean Difference (IV, Random, 95% CI)","0.00 [‐1.85, 1.85]",Dose reduction versus dose maintenance,1,0.0,-1.85,1.85,1,58,,< 3 months
1.58.2 < 6 months,1,20,"Mean Difference (IV, Random, 95% CI)","0.97 [‐0.55, 2.49]",Dose reduction versus dose maintenance,1,0.97,-0.55,2.49,1,58,,< 6 months
1.59 Mental state ‐ specific: mean change PANSS depression/anxiety (high = poor) Show forest plot,4,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,59,,Mental state ‐ specific: mean change PANSS depression/anxiety (high = poor) Show forest plot
1.59.1 < 3 months,1,20,"Mean Difference (IV, Random, 95% CI)","‐0.55 [‐2.41, 1.31]",Dose reduction versus dose maintenance,1,-0.55,-2.41,1.31,1,59,,< 3 months
1.59.2 < 6 months,2,117,"Mean Difference (IV, Random, 95% CI)","0.49 [‐0.45, 1.42]",Dose reduction versus dose maintenance,1,0.49,-0.45,1.42,1,59,,< 6 months
1.59.3 < 1 year,2,737,"Mean Difference (IV, Random, 95% CI)","0.26 [‐0.08, 0.60]",Dose reduction versus dose maintenance,1,0.26,-0.08,0.6,1,59,,< 1 year
"1.60 Mental state ‐ specific: mean endpoint/change depression (PANSS depression, CDSS) (combined time points) Show forest plot",5,915,"Std. Mean Difference (IV, Random, 95% CI)","0.11 [‐0.02, 0.25]",Dose reduction versus dose maintenance,1,0.11,-0.02,0.25,1,60,,"Mental state ‐ specific: mean endpoint/change depression (PANSS depression, CDSS) (combined time points) Show forest plot"
"1.61 Mental state ‐ specific: mean endpoint/change depression (PANSS depression, CDSS) (separated time points) Show forest plot",5,,"Std. Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,61,,"Mental state ‐ specific: mean endpoint/change depression (PANSS depression, CDSS) (separated time points) Show forest plot"
1.61.1 < 3 months,1,20,"Std. Mean Difference (IV, Random, 95% CI)","0.00 [‐0.88, 0.88]",Dose reduction versus dose maintenance,1,0.0,-0.88,0.88,1,61,,< 3 months
1.61.2 < 6 months,2,117,"Std. Mean Difference (IV, Random, 95% CI)","0.25 [‐0.12, 0.61]",Dose reduction versus dose maintenance,1,0.25,-0.12,0.61,1,61,,< 6 months
1.61.3 < 1 year,3,798,"Std. Mean Difference (IV, Random, 95% CI)","0.09 [‐0.06, 0.23]",Dose reduction versus dose maintenance,1,0.09,-0.06,0.23,1,61,,< 1 year
1.62 Mental state ‐ specific: mean change POMS‐SF (high = poor) Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,62,,Mental state ‐ specific: mean change POMS‐SF (high = poor) Show forest plot
1.62.1 < 1 year,1,61,"Mean Difference (IV, Random, 95% CI)","3.60 [‐1.68, 8.88]",Dose reduction versus dose maintenance,1,3.6,-1.68,8.88,1,62,,< 1 year
1.63 Mental state ‐ specific: mean change SAI (high = good) Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,63,,Mental state ‐ specific: mean change SAI (high = good) Show forest plot
1.63.1 < 1 year,1,61,"Mean Difference (IV, Random, 95% CI)","‐0.10 [‐2.62, 2.42]",Dose reduction versus dose maintenance,1,-0.1,-2.62,2.42,1,63,,< 1 year
1.64 Behaviour ‐ mean endpoint PANSS excitement/hostility (high = poor) Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,64,,Behaviour ‐ mean endpoint PANSS excitement/hostility (high = poor) Show forest plot
1.64.1 < 3 months,1,20,"Mean Difference (IV, Random, 95% CI)","‐1.62 [‐2.98, ‐0.26]",Dose reduction versus dose maintenance,1,-1.62,-2.98,-0.26,1,64,,< 3 months
1.64.2 < 6 months,1,20,"Mean Difference (IV, Random, 95% CI)","‐0.75 [‐2.07, 0.57]",Dose reduction versus dose maintenance,1,-0.75,-2.07,0.57,1,64,,< 6 months
1.65 Behaviour ‐ mean change PANSS excitement/hostility (high = poor) Show forest plot,3,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,65,,Behaviour ‐ mean change PANSS excitement/hostility (high = poor) Show forest plot
1.65.1 < 3 months,1,20,"Mean Difference (IV, Random, 95% CI)","‐1.62 [‐3.05, ‐0.19]",Dose reduction versus dose maintenance,1,-1.62,-3.05,-0.19,1,65,,< 3 months
1.65.2 < 6 months,1,20,"Mean Difference (IV, Random, 95% CI)","‐0.74 [‐2.20, 0.72]",Dose reduction versus dose maintenance,1,-0.74,-2.2,0.72,1,65,,< 6 months
1.65.3 <1 year,2,737,"Mean Difference (IV, Random, 95% CI)","0.40 [‐0.07, 0.86]",Dose reduction versus dose maintenance,1,0.4,-0.07,0.86,1,65,,<1 year
1.66 Behaviour ‐ mean endpoint/change aggressive behaviour (PANSS excitement/hostility) (high = poor) (combined time points) Show forest plot,3,757,"Mean Difference (IV, Random, 95% CI)","0.25 [‐0.32, 0.82]",Dose reduction versus dose maintenance,1,0.25,-0.32,0.82,1,66,,Behaviour ‐ mean endpoint/change aggressive behaviour (PANSS excitement/hostility) (high = poor) (combined time points) Show forest plot
1.67 Behaviour ‐ mean endpoint/change aggressive behaviour (PANSS excitement/hostility) (high = poor) (separated time points) Show forest plot,3,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,67,,Behaviour ‐ mean endpoint/change aggressive behaviour (PANSS excitement/hostility) (high = poor) (separated time points) Show forest plot
1.67.1 < 3 months,1,20,"Mean Difference (IV, Random, 95% CI)","‐1.62 [‐2.98, ‐0.26]",Dose reduction versus dose maintenance,1,-1.62,-2.98,-0.26,1,67,,< 3 months
1.67.2 < 6 months,1,20,"Mean Difference (IV, Random, 95% CI)","‐0.75 [‐2.07, 0.57]",Dose reduction versus dose maintenance,1,-0.75,-2.07,0.57,1,67,,< 6 months
1.67.3 <1 year,2,737,"Mean Difference (IV, Random, 95% CI)","0.40 [‐0.07, 0.86]",Dose reduction versus dose maintenance,1,0.4,-0.07,0.86,1,67,,<1 year
1.68 Satisfaction with care ‐ number of participants with clinically important change in satisfaction with care (PSMQ‐Modified preference to current medication) Show forest plot,1,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,68,,Satisfaction with care ‐ number of participants with clinically important change in satisfaction with care (PSMQ‐Modified preference to current medication) Show forest plot
1.68.1 < 1 year,1,397,"Risk Ratio (IV, Random, 95% CI)","0.86 [0.77, 0.96]",Dose reduction versus dose maintenance,1,0.86,0.77,0.96,1,68,,< 1 year
1.69 Satisfaction with care ‐ mean endpoint MARS (high = poor) Show forest plot,1,40,"Mean Difference (IV, Fixed, 95% CI)","0.61 [‐0.09, 1.31]",Dose reduction versus dose maintenance,1,0.61,-0.09,1.31,1,69,,Satisfaction with care ‐ mean endpoint MARS (high = poor) Show forest plot
1.69.1 < 3 months,1,20,"Mean Difference (IV, Fixed, 95% CI)","0.80 [‐0.19, 1.79]",Dose reduction versus dose maintenance,1,0.8,-0.19,1.79,1,69,,< 3 months
1.69.2 < 6 months,1,20,"Mean Difference (IV, Fixed, 95% CI)","0.42 [‐0.57, 1.41]",Dose reduction versus dose maintenance,1,0.42,-0.57,1.41,1,69,,< 6 months
1.70 Satisfaction with care ‐ mean change MARS (high = poor) Show forest plot,1,40,"Mean Difference (IV, Random, 95% CI)","0.27 [‐0.39, 0.93]",Dose reduction versus dose maintenance,1,0.27,-0.39,0.93,1,70,,Satisfaction with care ‐ mean change MARS (high = poor) Show forest plot
1.70.1 < 3 months,1,20,"Mean Difference (IV, Random, 95% CI)","0.44 [‐0.44, 1.32]",Dose reduction versus dose maintenance,1,0.44,-0.44,1.32,1,70,,< 3 months
1.70.2 < 6 months,1,20,"Mean Difference (IV, Random, 95% CI)","0.06 [‐0.92, 1.04]",Dose reduction versus dose maintenance,1,0.06,-0.92,1.04,1,70,,< 6 months
1.71 Satisfaction with care ‐ mean change DAI‐10 (high = poor) Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,71,,Satisfaction with care ‐ mean change DAI‐10 (high = poor) Show forest plot
1.71.1 < 1 year,1,61,"Mean Difference (IV, Random, 95% CI)","‐1.10 [‐2.83, 0.63]",Dose reduction versus dose maintenance,1,-1.1,-2.83,0.63,1,71,,< 1 year
1.72 Satisfaction with care ‐ mean endpoint DAI‐30 (high = poor) Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,72,,Satisfaction with care ‐ mean endpoint DAI‐30 (high = poor) Show forest plot
1.72.1 < 1 year,1,359,"Mean Difference (IV, Random, 95% CI)","‐1.00 [‐6.65, 4.65]",Dose reduction versus dose maintenance,1,-1.0,-6.65,4.65,1,72,,< 1 year
1.73 Satisfaction with care ‐ mean change MAQ (high = poor) Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,73,,Satisfaction with care ‐ mean change MAQ (high = poor) Show forest plot
1.73.1 < 1 year,1,346,"Mean Difference (IV, Random, 95% CI)","‐0.05 [‐0.26, 0.16]",Dose reduction versus dose maintenance,1,-0.05,-0.26,0.16,1,73,,< 1 year
1.74 Satisfaction with care ‐ mean endpoint MAQ (high = poor) Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,74,,Satisfaction with care ‐ mean endpoint MAQ (high = poor) Show forest plot
1.74.1 < 1 year,1,362,"Mean Difference (IV, Random, 95% CI)","‐0.01 [‐0.21, 0.19]",Dose reduction versus dose maintenance,1,-0.01,-0.21,0.19,1,74,,< 1 year
"1.75 Satisfaction with care ‐ mean endpoint/change adherence scales (MARS, DAI, MAQ) (high = poor) (combined time points) Show forest plot",3,440,"Std. Mean Difference (IV, Random, 95% CI)","‐0.06 [‐0.26, 0.14]",Dose reduction versus dose maintenance,1,-0.06,-0.26,0.14,1,75,,"Satisfaction with care ‐ mean endpoint/change adherence scales (MARS, DAI, MAQ) (high = poor) (combined time points) Show forest plot"
"1.76 Satisfaction with care ‐ mean endpoint/change adherence scales (MARS, DAI, MAQ) (high = poor) (separated time points) Show forest plot",3,,"Std. Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,76,,"Satisfaction with care ‐ mean endpoint/change adherence scales (MARS, DAI, MAQ) (high = poor) (separated time points) Show forest plot"
1.76.1 < 3 months,1,20,"Std. Mean Difference (IV, Random, 95% CI)","0.68 [‐0.23, 1.59]",Dose reduction versus dose maintenance,1,0.68,-0.23,1.59,1,76,,< 3 months
1.76.2 < 6 months,1,20,"Std. Mean Difference (IV, Random, 95% CI)","0.36 [‐0.53, 1.25]",Dose reduction versus dose maintenance,1,0.36,-0.53,1.25,1,76,,< 6 months
1.76.3 < 1 year,2,420,"Std. Mean Difference (IV, Random, 95% CI)","‐0.08 [‐0.29, 0.12]",Dose reduction versus dose maintenance,1,-0.08,-0.29,0.12,1,76,,< 1 year
1.77 Adverse effects ‐ number of participants with at least 1 adverse effect (combined time points) Show forest plot,5,998,"Risk Ratio (IV, Random, 95% CI)","1.03 [0.94, 1.12]",Dose reduction versus dose maintenance,1,1.03,0.94,1.12,1,77,,Adverse effects ‐ number of participants with at least 1 adverse effect (combined time points) Show forest plot
1.78 Adverse effects ‐ number of participants with at least 1 adverse effect (separated time points) Show forest plot,5,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,78,,Adverse effects ‐ number of participants with at least 1 adverse effect (separated time points) Show forest plot
1.78.1 < 3 months,2,38,"Risk Ratio (IV, Random, 95% CI)","0.92 [0.71, 1.19]",Dose reduction versus dose maintenance,1,0.92,0.71,1.19,1,78,,< 3 months
1.78.2 < 6 months,4,601,"Risk Ratio (IV, Random, 95% CI)","1.06 [0.92, 1.23]",Dose reduction versus dose maintenance,1,1.06,0.92,1.23,1,78,,< 6 months
1.78.3 < 1 year,2,415,"Risk Ratio (IV, Random, 95% CI)","1.01 [0.91, 1.12]",Dose reduction versus dose maintenance,1,1.01,0.91,1.12,1,78,,< 1 year
1.79 Adverse effects ‐ number of participants with at least 1 serious adverse event (combined time points) Show forest plot,2,417,"Risk Ratio (IV, Random, 95% CI)","1.49 [0.70, 3.15]",Dose reduction versus dose maintenance,1,1.49,0.7,3.15,1,79,,Adverse effects ‐ number of participants with at least 1 serious adverse event (combined time points) Show forest plot
1.80 Adverse effects ‐ number of participants with at least 1 serious adverse event (separated time points) Show forest plot,2,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,80,,Adverse effects ‐ number of participants with at least 1 serious adverse event (separated time points) Show forest plot
1.80.1 < 3 months,1,20,"Risk Ratio (IV, Random, 95% CI)",Not estimable,Dose reduction versus dose maintenance,1,,,,1,80,,< 3 months
1.80.2 < 6 months,1,20,"Risk Ratio (IV, Random, 95% CI)",Not estimable,Dose reduction versus dose maintenance,1,,,,1,80,,< 6 months
1.80.3 < 1 year,1,397,"Risk Ratio (IV, Random, 95% CI)","1.49 [0.70, 3.15]",Dose reduction versus dose maintenance,1,1.49,0.7,3.15,1,80,,< 1 year
"1.81 Adverse effects ‐ mean endpoint/change adverse effect scales (LUNSERS, UKU) (high = poor) (combined time points) Show forest plot",2,147,"Std. Mean Difference (IV, Random, 95% CI)","‐0.01 [‐0.34, 0.31]",Dose reduction versus dose maintenance,1,-0.01,-0.34,0.31,1,81,,"Adverse effects ‐ mean endpoint/change adverse effect scales (LUNSERS, UKU) (high = poor) (combined time points) Show forest plot"
"1.82 Adverse effects ‐ mean endpoint/change adverse effect scales (LUNSERS, UKU) (high = poor) (separated time points) Show forest plot",2,,"Std. Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,82,,"Adverse effects ‐ mean endpoint/change adverse effect scales (LUNSERS, UKU) (high = poor) (separated time points) Show forest plot"
1.82.1 < 3 months,1,19,"Std. Mean Difference (IV, Random, 95% CI)","‐0.15 [‐1.05, 0.76]",Dose reduction versus dose maintenance,1,-0.15,-1.05,0.76,1,82,,< 3 months
1.82.2 < 6 months,1,19,"Std. Mean Difference (IV, Random, 95% CI)","‐0.12 [‐1.02, 0.79]",Dose reduction versus dose maintenance,1,-0.12,-1.02,0.79,1,82,,< 6 months
1.82.3 < 1 year,1,128,"Std. Mean Difference (IV, Random, 95% CI)","0.00 [‐0.35, 0.35]",Dose reduction versus dose maintenance,1,0.0,-0.35,0.35,1,82,,< 1 year
1.82.4 > 1 year,1,128,"Std. Mean Difference (IV, Random, 95% CI)","0.08 [‐0.27, 0.42]",Dose reduction versus dose maintenance,1,0.08,-0.27,0.42,1,82,,> 1 year
1.83 Adverse effects ‐ mean endpoint LUNSERS (high = poor) Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,83,,Adverse effects ‐ mean endpoint LUNSERS (high = poor) Show forest plot
1.83.1 < 1 year,1,128,"Mean Difference (IV, Random, 95% CI)","0.00 [‐4.97, 4.97]",Dose reduction versus dose maintenance,1,0.0,-4.97,4.97,1,83,,< 1 year
1.83.2 > 1 year,1,128,"Mean Difference (IV, Random, 95% CI)","2.30 [‐7.76, 12.36]",Dose reduction versus dose maintenance,1,2.3,-7.76,12.36,1,83,,> 1 year
1.84 Adverse effects ‐ mean endpoint UKU (high = poor) Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,84,,Adverse effects ‐ mean endpoint UKU (high = poor) Show forest plot
1.84.1 < 3 months,1,19,"Mean Difference (IV, Random, 95% CI)","‐1.21 [‐8.16, 5.74]",Dose reduction versus dose maintenance,1,-1.21,-8.16,5.74,1,84,,< 3 months
1.84.2 < 6 months,1,19,"Mean Difference (IV, Random, 95% CI)","‐1.08 [‐9.24, 7.08]",Dose reduction versus dose maintenance,1,-1.08,-9.24,7.08,1,84,,< 6 months
1.85 Adverse effects ‐ number of participants with clinically important weight gain (combined time points) Show forest plot,3,883,"Risk Ratio (IV, Random, 95% CI)","0.39 [0.25, 0.61]",Dose reduction versus dose maintenance,1,0.39,0.25,0.61,1,85,,Adverse effects ‐ number of participants with clinically important weight gain (combined time points) Show forest plot
1.86 Adverse effects ‐ number of participants with clinically important weight gain (separated time points) Show forest plot,3,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,86,,Adverse effects ‐ number of participants with clinically important weight gain (separated time points) Show forest plot
1.86.1 < 3 months,1,20,"Risk Ratio (IV, Random, 95% CI)",Not estimable,Dose reduction versus dose maintenance,1,,,,1,86,,< 3 months
1.86.2 < 6 months,2,486,"Risk Ratio (IV, Random, 95% CI)","0.39 [0.22, 0.71]",Dose reduction versus dose maintenance,1,0.39,0.22,0.71,1,86,,< 6 months
1.86.3 < 1 year,1,397,"Risk Ratio (IV, Random, 95% CI)","0.38 [0.18, 0.78]",Dose reduction versus dose maintenance,1,0.38,0.18,0.78,1,86,,< 1 year
"1.87 Adverse effects ‐ mean endpoint/change weight (kg, %, BMI) (combined time points) Show forest plot",8,1175,"Std. Mean Difference (IV, Random, 95% CI)","‐0.22 [‐0.50, 0.06]",Dose reduction versus dose maintenance,1,-0.22,-0.5,0.06,1,87,,"Adverse effects ‐ mean endpoint/change weight (kg, %, BMI) (combined time points) Show forest plot"
1.88 Adverse effects ‐ mean endpoint/change weight (kg) (combined time points) Show forest plot,6,1074,"Mean Difference (IV, Random, 95% CI)","‐0.80 [‐2.14, 0.53]",Dose reduction versus dose maintenance,1,-0.8,-2.14,0.53,1,88,,Adverse effects ‐ mean endpoint/change weight (kg) (combined time points) Show forest plot
1.89 Adverse effects ‐ mean endpoint/change weight (kg) (separated time points) Show forest plot,6,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,89,,Adverse effects ‐ mean endpoint/change weight (kg) (separated time points) Show forest plot
1.89.1 < 3 months,1,18,"Mean Difference (IV, Random, 95% CI)","0.40 [‐1.10, 1.90]",Dose reduction versus dose maintenance,1,0.4,-1.1,1.9,1,89,,< 3 months
1.89.2 < 6 months,3,581,"Mean Difference (IV, Random, 95% CI)","‐1.50 [‐2.71, ‐0.29]",Dose reduction versus dose maintenance,1,-1.5,-2.71,-0.29,1,89,,< 6 months
1.89.3 < 1 year,3,493,"Mean Difference (IV, Random, 95% CI)","‐0.03 [‐2.80, 2.73]",Dose reduction versus dose maintenance,1,-0.03,-2.8,2.73,1,89,,< 1 year
1.90 Adverse effects ‐ mean change weight (kg) Show forest plot,6,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,90,,Adverse effects ‐ mean change weight (kg) Show forest plot
1.90.1 < 3 months,1,18,"Mean Difference (IV, Random, 95% CI)","0.40 [‐1.10, 1.90]",Dose reduction versus dose maintenance,1,0.4,-1.1,1.9,1,90,,< 3 months
1.90.2 < 6 months,3,581,"Mean Difference (IV, Random, 95% CI)","‐1.50 [‐2.71, ‐0.29]",Dose reduction versus dose maintenance,1,-1.5,-2.71,-0.29,1,90,,< 6 months
1.90.3 < 1 year,3,493,"Mean Difference (IV, Random, 95% CI)","‐0.03 [‐2.80, 2.73]",Dose reduction versus dose maintenance,1,-0.03,-2.8,2.73,1,90,,< 1 year
1.91 Adverse effects ‐ mean weight endpoint (kg) Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,91,,Adverse effects ‐ mean weight endpoint (kg) Show forest plot
1.91.1 < 3 months,1,19,"Mean Difference (IV, Random, 95% CI)","13.58 [0.62, 26.54]",Dose reduction versus dose maintenance,1,13.58,0.62,26.54,1,91,,< 3 months
1.91.2 < 6 months,1,19,"Mean Difference (IV, Random, 95% CI)","11.52 [‐1.40, 24.45]",Dose reduction versus dose maintenance,1,11.52,-1.4,24.45,1,91,,< 6 months
1.92 Adverse effects ‐ weight change in % from baseline to endpoint Show forest plot,1,26,"Mean Difference (IV, Random, 95% CI)","1.00 [‐0.60, 2.60]",Dose reduction versus dose maintenance,1,1.0,-0.6,2.6,1,92,,Adverse effects ‐ weight change in % from baseline to endpoint Show forest plot
1.93 Adverse effects ‐ mean endpoint BMI (kg/m2) Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,93,,Adverse effects ‐ mean endpoint BMI (kg/m2) Show forest plot
1.93.1 < 3 months,1,75,"Mean Difference (IV, Random, 95% CI)","‐2.30 [‐4.66, 0.06]",Dose reduction versus dose maintenance,1,-2.3,-4.66,0.06,1,93,,< 3 months
1.93.2 < 6 months,1,75,"Mean Difference (IV, Random, 95% CI)","‐2.20 [‐4.49, 0.09]",Dose reduction versus dose maintenance,1,-2.2,-4.49,0.09,1,93,,< 6 months
1.93.3 < 1 year,1,75,"Mean Difference (IV, Random, 95% CI)","‐3.20 [‐5.29, ‐1.11]",Dose reduction versus dose maintenance,1,-3.2,-5.29,-1.11,1,93,,< 1 year
1.94 Adverse effects ‐ specific: number of participants that needed antiparkinsonian medication Show forest plot,2,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,94,,Adverse effects ‐ specific: number of participants that needed antiparkinsonian medication Show forest plot
1.94.1 < 3 months,1,20,"Risk Ratio (IV, Random, 95% CI)",Not estimable,Dose reduction versus dose maintenance,1,,,,1,94,,< 3 months
1.94.2 < 6 months,1,20,"Risk Ratio (IV, Random, 95% CI)",Not estimable,Dose reduction versus dose maintenance,1,,,,1,94,,< 6 months
1.94.3 < 1 year,1,397,"Risk Ratio (IV, Random, 95% CI)","0.79 [0.48, 1.31]",Dose reduction versus dose maintenance,1,0.79,0.48,1.31,1,94,,< 1 year
1.95 Adverse effects ‐ specific: number of participants with at least 1 extrapyramidal symptom (combined time points) Show forest plot,2,417,"Risk Ratio (IV, Random, 95% CI)","1.06 [0.63, 1.76]",Dose reduction versus dose maintenance,1,1.06,0.63,1.76,1,95,,Adverse effects ‐ specific: number of participants with at least 1 extrapyramidal symptom (combined time points) Show forest plot
1.96 Adverse effects ‐ specific: number of participants with at least 1 extrapyramidal symptom (separated time points) Show forest plot,2,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,96,,Adverse effects ‐ specific: number of participants with at least 1 extrapyramidal symptom (separated time points) Show forest plot
1.96.1 < 3 months,1,20,"Risk Ratio (IV, Random, 95% CI)","0.82 [0.34, 1.96]",Dose reduction versus dose maintenance,1,0.82,0.34,1.96,1,96,,< 3 months
1.96.2 < 6 months,1,20,"Risk Ratio (IV, Random, 95% CI)","1.09 [0.33, 3.66]",Dose reduction versus dose maintenance,1,1.09,0.33,3.66,1,96,,< 6 months
1.96.3 < 1 year,1,397,"Risk Ratio (IV, Random, 95% CI)","1.05 [0.60, 1.85]",Dose reduction versus dose maintenance,1,1.05,0.6,1.85,1,96,,< 1 year
1.97 Adverse effects ‐ specific: number of participants with parkinsonism Show forest plot,2,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,97,,Adverse effects ‐ specific: number of participants with parkinsonism Show forest plot
1.97.1 < 6 months,1,466,"Risk Ratio (IV, Random, 95% CI)","0.75 [0.08, 7.10]",Dose reduction versus dose maintenance,1,0.75,0.08,7.1,1,97,,< 6 months
1.97.2 < 1 year,1,397,"Risk Ratio (IV, Random, 95% CI)","1.29 [0.51, 3.26]",Dose reduction versus dose maintenance,1,1.29,0.51,3.26,1,97,,< 1 year
1.98 Adverse effects ‐ specific: number of participants with rigidity Show forest plot,2,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,98,,Adverse effects ‐ specific: number of participants with rigidity Show forest plot
1.98.1 < 3 months,1,20,"Risk Ratio (IV, Random, 95% CI)","2.50 [0.11, 54.87]",Dose reduction versus dose maintenance,1,2.5,0.11,54.87,1,98,,< 3 months
1.98.2 < 6 months,2,486,"Risk Ratio (IV, Random, 95% CI)","2.50 [0.11, 54.87]",Dose reduction versus dose maintenance,1,2.5,0.11,54.87,1,98,,< 6 months
1.99 Adverse effects ‐ specific: number of participants with tremors Show forest plot,2,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,99,,Adverse effects ‐ specific: number of participants with tremors Show forest plot
1.99.1 < 3 months,1,20,"Risk Ratio (IV, Random, 95% CI)","0.82 [0.22, 3.11]",Dose reduction versus dose maintenance,1,0.82,0.22,3.11,1,99,,< 3 months
1.99.2 < 6 months,2,486,"Risk Ratio (IV, Random, 95% CI)","0.57 [0.14, 2.24]",Dose reduction versus dose maintenance,1,0.57,0.14,2.24,1,99,,< 6 months
1.100 Adverse effects ‐ specific: number of participants with dystonia Show forest plot,1,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,100,,Adverse effects ‐ specific: number of participants with dystonia Show forest plot
1.100.1 < 3 months,1,20,"Risk Ratio (IV, Random, 95% CI)","2.50 [0.11, 54.87]",Dose reduction versus dose maintenance,1,2.5,0.11,54.87,1,100,,< 3 months
1.100.2 < 6 months,1,20,"Risk Ratio (IV, Random, 95% CI)","0.82 [0.06, 11.33]",Dose reduction versus dose maintenance,1,0.82,0.06,11.33,1,100,,< 6 months
1.101 Adverse effects ‐ mean endpoint SAS (high = poor) Show forest plot,2,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,101,,Adverse effects ‐ mean endpoint SAS (high = poor) Show forest plot
1.101.1 < 3 months,1,75,"Mean Difference (IV, Random, 95% CI)","‐1.10 [‐2.35, 0.15]",Dose reduction versus dose maintenance,1,-1.1,-2.35,0.15,1,101,,< 3 months
1.101.2 < 6 months,1,75,"Mean Difference (IV, Random, 95% CI)","‐0.80 [‐2.07, 0.47]",Dose reduction versus dose maintenance,1,-0.8,-2.07,0.47,1,101,,< 6 months
1.101.3 < 1 year,2,110,"Mean Difference (IV, Random, 95% CI)","‐0.66 [‐3.79, 2.48]",Dose reduction versus dose maintenance,1,-0.66,-3.79,2.48,1,101,,< 1 year
1.102 Adverse effects ‐ mean change SAS (high = poor) Show forest plot,6,,"Std. Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,102,,Adverse effects ‐ mean change SAS (high = poor) Show forest plot
1.102.1 < 3 months,1,20,"Std. Mean Difference (IV, Random, 95% CI)","‐0.23 [‐1.12, 0.65]",Dose reduction versus dose maintenance,1,-0.23,-1.12,0.65,1,102,,< 3 months
1.102.2 < 6 months,2,563,"Std. Mean Difference (IV, Random, 95% CI)","‐0.14 [‐0.31, 0.04]",Dose reduction versus dose maintenance,1,-0.14,-0.31,0.04,1,102,,< 6 months
1.102.3 < 1 year,3,763,"Std. Mean Difference (IV, Random, 95% CI)","‐0.03 [‐0.17, 0.12]",Dose reduction versus dose maintenance,1,-0.03,-0.17,0.12,1,102,,< 1 year
1.103 Adverse effects ‐ mean change DIEPSS (high = poor) Show forest plot,1,,"Mean Difference (IV, Fixed, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,103,,Adverse effects ‐ mean change DIEPSS (high = poor) Show forest plot
1.103.1 < 1 year,1,61,"Mean Difference (IV, Fixed, 95% CI)","‐1.00 [‐1.74, ‐0.26]",Dose reduction versus dose maintenance,1,-1.0,-1.74,-0.26,1,103,,< 1 year
1.104 Adverse effects ‐ mean endpoint MPRC parkinsonian scale (high = poor) Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,104,,Adverse effects ‐ mean endpoint MPRC parkinsonian scale (high = poor) Show forest plot
1.104.1 < 6 months,1,50,"Mean Difference (IV, Random, 95% CI)","0.70 [‐0.66, 2.06]",Dose reduction versus dose maintenance,1,0.7,-0.66,2.06,1,104,,< 6 months
1.104.2 < 1 year,1,50,"Mean Difference (IV, Random, 95% CI)","‐0.20 [‐1.56, 1.16]",Dose reduction versus dose maintenance,1,-0.2,-1.56,1.16,1,104,,< 1 year
"1.105 Adverse effects ‐ mean endpoint/change EPS scales (SAS, DIEPSS, MPRC parkinsonian) (high = poor) (combined time points) Show forest plot",9,1532,"Std. Mean Difference (IV, Random, 95% CI)","‐0.17 [‐0.32, ‐0.03]",Dose reduction versus dose maintenance,1,-0.17,-0.32,-0.03,1,105,,"Adverse effects ‐ mean endpoint/change EPS scales (SAS, DIEPSS, MPRC parkinsonian) (high = poor) (combined time points) Show forest plot"
"1.106 Adverse effects ‐ mean endpoint/change EPS scales (SAS, DIEPSS, MPRC parkinsonian) (high = poor) (separated time points) Show forest plot",9,,"Std. Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,106,,"Adverse effects ‐ mean endpoint/change EPS scales (SAS, DIEPSS, MPRC parkinsonian) (high = poor) (separated time points) Show forest plot"
1.106.1 < 3 months,2,95,"Std. Mean Difference (IV, Random, 95% CI)","‐0.36 [‐0.77, 0.04]",Dose reduction versus dose maintenance,1,-0.36,-0.77,0.04,1,106,,< 3 months
1.106.2 < 6 months,4,688,"Std. Mean Difference (IV, Random, 95% CI)","‐0.12 [‐0.28, 0.04]",Dose reduction versus dose maintenance,1,-0.12,-0.28,0.04,1,106,,< 6 months
1.106.3 < 1 year,6,949,"Std. Mean Difference (IV, Random, 95% CI)","‐0.22 [‐0.46, 0.01]",Dose reduction versus dose maintenance,1,-0.22,-0.46,0.01,1,106,,< 1 year
1.107 Adverse effects ‐ specific: number of participants with akathisia (combined time points) Show forest plot,3,883,"Risk Ratio (IV, Random, 95% CI)","1.07 [0.55, 2.09]",Dose reduction versus dose maintenance,1,1.07,0.55,2.09,1,107,,Adverse effects ‐ specific: number of participants with akathisia (combined time points) Show forest plot
1.108 Adverse effects ‐ specific: number of participants with akathisia (separated time points) Show forest plot,3,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,108,,Adverse effects ‐ specific: number of participants with akathisia (separated time points) Show forest plot
1.108.1 < 3 months,1,20,"Risk Ratio (IV, Random, 95% CI)","1.23 [0.26, 5.82]",Dose reduction versus dose maintenance,1,1.23,0.26,5.82,1,108,,< 3 months
1.108.2 < 6 months,2,486,"Risk Ratio (IV, Random, 95% CI)","0.42 [0.07, 2.54]",Dose reduction versus dose maintenance,1,0.42,0.07,2.54,1,108,,< 6 months
1.108.3 < 1 year,1,397,"Risk Ratio (IV, Random, 95% CI)","1.24 [0.60, 2.55]",Dose reduction versus dose maintenance,1,1.24,0.6,2.55,1,108,,< 1 year
1.109 Adverse effects ‐ mean endpoint BARS (high = poor) Show forest plot,1,35,"Mean Difference (IV, Fixed, 95% CI)","0.10 [0.00, 0.20]",Dose reduction versus dose maintenance,1,0.1,0.0,0.2,1,109,,Adverse effects ‐ mean endpoint BARS (high = poor) Show forest plot
1.109.1 < 1 year,1,35,"Mean Difference (IV, Fixed, 95% CI)","0.10 [0.00, 0.20]",Dose reduction versus dose maintenance,1,0.1,0.0,0.2,1,109,,< 1 year
1.110 Adverse effects ‐ mean change BARS (high = poor) Show forest plot,4,,"Std. Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,110,,Adverse effects ‐ mean change BARS (high = poor) Show forest plot
1.110.1 < 6 months,2,563,"Std. Mean Difference (IV, Random, 95% CI)","‐0.03 [‐0.20, 0.15]",Dose reduction versus dose maintenance,1,-0.03,-0.2,0.15,1,110,,< 6 months
1.110.2 < 1 year,2,423,"Std. Mean Difference (IV, Random, 95% CI)","‐0.35 [‐1.08, 0.39]",Dose reduction versus dose maintenance,1,-0.35,-1.08,0.39,1,110,,< 1 year
1.111 Adverse effects ‐ mean endpoint/change BARS (high = poor) (separated and combined time points) Show forest plot,4,986,"Std. Mean Difference (IV, Random, 95% CI)","‐0.08 [‐0.26, 0.11]",Dose reduction versus dose maintenance,1,-0.08,-0.26,0.11,1,111,,Adverse effects ‐ mean endpoint/change BARS (high = poor) (separated and combined time points) Show forest plot
1.111.1 < 6 months,2,563,"Std. Mean Difference (IV, Random, 95% CI)","‐0.03 [‐0.20, 0.15]",Dose reduction versus dose maintenance,1,-0.03,-0.2,0.15,1,111,,< 6 months
1.111.2 < 1 year,2,423,"Std. Mean Difference (IV, Random, 95% CI)","‐0.35 [‐1.08, 0.39]",Dose reduction versus dose maintenance,1,-0.35,-1.08,0.39,1,111,,< 1 year
1.112 Adverse effects ‐ specific: number of participants with dyskinesia (including tardive dyskinesia) (combined time points) Show forest plot,4,630,"Risk Ratio (IV, Random, 95% CI)","0.83 [0.02, 38.90]",Dose reduction versus dose maintenance,1,0.83,0.02,38.9,1,112,,Adverse effects ‐ specific: number of participants with dyskinesia (including tardive dyskinesia) (combined time points) Show forest plot
1.113 Adverse effects ‐ specific: number of participants with dyskinesia (including tardive dyskinesia) (separated time points) Show forest plot,4,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,113,,Adverse effects ‐ specific: number of participants with dyskinesia (including tardive dyskinesia) (separated time points) Show forest plot
1.113.1 < 3 months,2,38,"Risk Ratio (IV, Random, 95% CI)","0.82 [0.06, 11.33]",Dose reduction versus dose maintenance,1,0.82,0.06,11.33,1,113,,< 3 months
1.113.2 < 6 months,3,504,"Risk Ratio (IV, Random, 95% CI)","5.83 [0.34, 100.03]",Dose reduction versus dose maintenance,1,5.83,0.34,100.03,1,113,,< 6 months
1.113.3 < 1 year,2,144,"Risk Ratio (IV, Random, 95% CI)","0.11 [0.01, 2.09]",Dose reduction versus dose maintenance,1,0.11,0.01,2.09,1,113,,< 1 year
1.114 Adverse effects ‐ mean endpoint AIMS (high = poor) Show forest plot,4,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,114,,Adverse effects ‐ mean endpoint AIMS (high = poor) Show forest plot
1.114.1 < 3 months,3,105,"Mean Difference (IV, Random, 95% CI)","‐0.26 [‐0.69, 0.18]",Dose reduction versus dose maintenance,1,-0.26,-0.69,0.18,1,114,,< 3 months
1.114.2 < 6 months,3,105,"Mean Difference (IV, Random, 95% CI)","‐0.27 [‐0.71, 0.16]",Dose reduction versus dose maintenance,1,-0.27,-0.71,0.16,1,114,,< 6 months
1.114.3 < 1 year,2,94,"Mean Difference (IV, Random, 95% CI)","‐0.24 [‐2.26, 1.78]",Dose reduction versus dose maintenance,1,-0.24,-2.26,1.78,1,114,,< 1 year
1.115 Adverse effects ‐ mean change AIMS (high = poor) Show forest plot,5,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,115,,Adverse effects ‐ mean change AIMS (high = poor) Show forest plot
1.115.1 < 3 months,1,20,"Mean Difference (IV, Random, 95% CI)","0.36 [‐1.51, 2.23]",Dose reduction versus dose maintenance,1,0.36,-1.51,2.23,1,115,,< 3 months
1.115.2 < 6 months,3,583,"Mean Difference (IV, Random, 95% CI)","0.09 [‐0.17, 0.35]",Dose reduction versus dose maintenance,1,0.09,-0.17,0.35,1,115,,< 6 months
1.115.3 < 1 year,2,423,"Mean Difference (IV, Random, 95% CI)","‐0.34 [‐1.23, 0.54]",Dose reduction versus dose maintenance,1,-0.34,-1.23,0.54,1,115,,< 1 year
1.116 Adverse effects ‐ mean endpoint MPRC dyskinesia scale (high = poor) Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,116,,Adverse effects ‐ mean endpoint MPRC dyskinesia scale (high = poor) Show forest plot
1.116.1 < 6 months,1,50,"Mean Difference (IV, Random, 95% CI)","1.30 [‐2.59, 5.19]",Dose reduction versus dose maintenance,1,1.3,-2.59,5.19,1,116,,< 6 months
1.116.2 < 12 months,1,50,"Mean Difference (IV, Random, 95% CI)","2.30 [‐1.59, 6.19]",Dose reduction versus dose maintenance,1,2.3,-1.59,6.19,1,116,,< 12 months
1.117 Adverse effects ‐ specific: mean endpoint abbreviated RTDRS (high = poor) Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,117,,Adverse effects ‐ specific: mean endpoint abbreviated RTDRS (high = poor) Show forest plot
1.117.1 < 3 months,1,21,"Mean Difference (IV, Random, 95% CI)","‐4.80 [‐10.51, 0.91]",Dose reduction versus dose maintenance,1,-4.8,-10.51,0.91,1,117,,< 3 months
1.117.2 < 6 months,1,21,"Mean Difference (IV, Random, 95% CI)","‐3.10 [‐8.81, 2.61]",Dose reduction versus dose maintenance,1,-3.1,-8.81,2.61,1,117,,< 6 months
"1.118 Adverse effects ‐ mean endpoint/change dyskinesia scales (AIMS, MRCP dyskinesia, RTDRS) (high = poor) (combined time points) Show forest plot",9,1162,"Std. Mean Difference (IV, Random, 95% CI)","‐0.01 [‐0.16, 0.14]",Dose reduction versus dose maintenance,1,-0.01,-0.16,0.14,1,118,,"Adverse effects ‐ mean endpoint/change dyskinesia scales (AIMS, MRCP dyskinesia, RTDRS) (high = poor) (combined time points) Show forest plot"
"1.119 Adverse effects ‐ mean endpoint/change dyskinesia scales (AIMS, MRCP dyskinesia, RTDRS) (high = poor) (separated time points) Show forest plot",9,,"Std. Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,119,,"Adverse effects ‐ mean endpoint/change dyskinesia scales (AIMS, MRCP dyskinesia, RTDRS) (high = poor) (separated time points) Show forest plot"
1.119.1 < 3 months,4,126,"Std. Mean Difference (IV, Random, 95% CI)","‐0.21 [‐0.57, 0.16]",Dose reduction versus dose maintenance,1,-0.21,-0.57,0.16,1,119,,< 3 months
1.119.2 < 6 months,7,739,"Std. Mean Difference (IV, Random, 95% CI)","0.02 [‐0.13, 0.17]",Dose reduction versus dose maintenance,1,0.02,-0.13,0.17,1,119,,< 6 months
1.119.3 < 1 year,4,532,"Std. Mean Difference (IV, Random, 95% CI)","‐0.06 [‐0.37, 0.25]",Dose reduction versus dose maintenance,1,-0.06,-0.37,0.25,1,119,,< 1 year
1.120 Adverse effects ‐ specific: number of participants with QTc prolongation Show forest plot,2,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,120,,Adverse effects ‐ specific: number of participants with QTc prolongation Show forest plot
1.120.1 < 6 months,1,466,"Risk Ratio (IV, Random, 95% CI)","2.24 [0.14, 35.50]",Dose reduction versus dose maintenance,1,2.24,0.14,35.5,1,120,,< 6 months
1.120.2 < 1 year,1,397,"Risk Ratio (IV, Random, 95% CI)",Not estimable,Dose reduction versus dose maintenance,1,,,,1,120,,< 1 year
1.121 Adverse effects ‐ mean change QTc interval (milliseconds) Show forest plot,3,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,121,,Adverse effects ‐ mean change QTc interval (milliseconds) Show forest plot
1.121.1 < 6 months,1,463,"Mean Difference (IV, Random, 95% CI)","‐0.03 [‐2.80, 2.74]",Dose reduction versus dose maintenance,1,-0.03,-2.8,2.74,1,121,,< 6 months
1.121.2 < 1 year,2,81,"Mean Difference (IV, Random, 95% CI)","4.13 [‐1.89, 10.15]",Dose reduction versus dose maintenance,1,4.13,-1.89,10.15,1,121,,< 1 year
1.122 Adverse effects ‐ specific: number of participants with arrhythmia Show forest plot,1,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,122,,Adverse effects ‐ specific: number of participants with arrhythmia Show forest plot
1.122.1 < 6 months,1,466,"Risk Ratio (IV, Random, 95% CI)","0.74 [0.03, 18.12]",Dose reduction versus dose maintenance,1,0.74,0.03,18.12,1,122,,< 6 months
1.123 Adverse effects ‐ specific: number of participants with hypotension Show forest plot,1,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,123,,Adverse effects ‐ specific: number of participants with hypotension Show forest plot
1.123.1 < 6 months,1,466,"Risk Ratio (IV, Random, 95% CI)","4.47 [0.41, 48.92]",Dose reduction versus dose maintenance,1,4.47,0.41,48.92,1,123,,< 6 months
1.124 Adverse effects ‐ specific: number of participants with bradycardia Show forest plot,1,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,124,,Adverse effects ‐ specific: number of participants with bradycardia Show forest plot
1.124.1 < 6 months,1,466,"Risk Ratio (IV, Random, 95% CI)",Not estimable,Dose reduction versus dose maintenance,1,,,,1,124,,< 6 months
1.125 Adverse effects ‐ specific: number of participants with tachycardia Show forest plot,2,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,125,,Adverse effects ‐ specific: number of participants with tachycardia Show forest plot
1.125.1 < 3 months,1,20,"Risk Ratio (IV, Random, 95% CI)","0.82 [0.06, 11.33]",Dose reduction versus dose maintenance,1,0.82,0.06,11.33,1,125,,< 3 months
1.125.2 < 6 months,2,486,"Risk Ratio (IV, Random, 95% CI)","1.09 [0.25, 4.79]",Dose reduction versus dose maintenance,1,1.09,0.25,4.79,1,125,,< 6 months
1.126 Adverse effects ‐ specific: number of participants with dizziness Show forest plot,2,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,126,,Adverse effects ‐ specific: number of participants with dizziness Show forest plot
1.126.1 < 3 months,1,20,"Risk Ratio (IV, Random, 95% CI)","1.64 [0.18, 15.26]",Dose reduction versus dose maintenance,1,1.64,0.18,15.26,1,126,,< 3 months
1.126.2 < 6 months,2,486,"Risk Ratio (IV, Random, 95% CI)","0.94 [0.36, 2.46]",Dose reduction versus dose maintenance,1,0.94,0.36,2.46,1,126,,< 6 months
1.127 Adverse effects ‐ specific: number of participants with increased prolactin Show forest plot,2,,"Risk Ratio (IV, Fixed, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,127,,Adverse effects ‐ specific: number of participants with increased prolactin Show forest plot
1.127.1 < 6 months,1,248,"Risk Ratio (IV, Fixed, 95% CI)","0.72 [0.31, 1.69]",Dose reduction versus dose maintenance,1,0.72,0.31,1.69,1,127,,< 6 months
1.127.2 < 1 year,1,397,"Risk Ratio (IV, Fixed, 95% CI)","1.35 [0.49, 3.72]",Dose reduction versus dose maintenance,1,1.35,0.49,3.72,1,127,,< 1 year
1.128 Adverse effects ‐ mean change prolactin levels (ng/mL) Show forest plot,4,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,128,,Adverse effects ‐ mean change prolactin levels (ng/mL) Show forest plot
1.128.1 < 6 months,1,466,"Mean Difference (IV, Random, 95% CI)","‐5.74 [‐8.95, ‐2.53]",Dose reduction versus dose maintenance,1,-5.74,-8.95,-2.53,1,128,,< 6 months
1.128.2 < 1 year,3,312,"Mean Difference (IV, Random, 95% CI)","‐0.24 [‐1.48, 1.00]",Dose reduction versus dose maintenance,1,-0.24,-1.48,1.0,1,128,,< 1 year
1.129 Adverse effects ‐ specific: number of participants (women) with amenorrhoea Show forest plot,1,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,129,,Adverse effects ‐ specific: number of participants (women) with amenorrhoea Show forest plot
1.129.1 < 3 months,1,8,"Risk Ratio (IV, Random, 95% CI)",Not estimable,Dose reduction versus dose maintenance,1,,,,1,129,,< 3 months
1.129.2 < 6 months,1,8,"Risk Ratio (IV, Random, 95% CI)","2.00 [0.11, 37.83]",Dose reduction versus dose maintenance,1,2.0,0.11,37.83,1,129,,< 6 months
1.130 Adverse effects ‐ specific: number of participants (men) with erectile dysfunction Show forest plot,2,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,130,,Adverse effects ‐ specific: number of participants (men) with erectile dysfunction Show forest plot
1.130.1 < 3 months,1,12,"Risk Ratio (IV, Random, 95% CI)",Not estimable,Dose reduction versus dose maintenance,1,,,,1,130,,< 3 months
1.130.2 < 6 months,2,317,"Risk Ratio (IV, Random, 95% CI)","4.32 [0.48, 38.83]",Dose reduction versus dose maintenance,1,4.32,0.48,38.83,1,130,,< 6 months
1.131 Adverse effects ‐ specific: number of participants with libido decreased Show forest plot,2,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,131,,Adverse effects ‐ specific: number of participants with libido decreased Show forest plot
1.131.1 < 3 months,1,20,"Risk Ratio (IV, Random, 95% CI)","0.55 [0.11, 2.59]",Dose reduction versus dose maintenance,1,0.55,0.11,2.59,1,131,,< 3 months
1.131.2 < 6 months,2,486,"Risk Ratio (IV, Random, 95% CI)","0.37 [0.06, 2.11]",Dose reduction versus dose maintenance,1,0.37,0.06,2.11,1,131,,< 6 months
1.132 Adverse effects ‐ specific: number of participants with libido increased Show forest plot,1,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,132,,Adverse effects ‐ specific: number of participants with libido increased Show forest plot
1.132.1 < 3 months,1,20,"Risk Ratio (IV, Random, 95% CI)",Not estimable,Dose reduction versus dose maintenance,1,,,,1,132,,< 3 months
1.132.2 < 6 months,1,20,"Risk Ratio (IV, Random, 95% CI)","2.50 [0.11, 54.87]",Dose reduction versus dose maintenance,1,2.5,0.11,54.87,1,132,,< 6 months
1.133 Adverse effects ‐ specific: number of participants with sedation Show forest plot,2,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,133,,Adverse effects ‐ specific: number of participants with sedation Show forest plot
1.133.1 < 3 months,1,20,"Risk Ratio (IV, Random, 95% CI)","0.82 [0.14, 4.71]",Dose reduction versus dose maintenance,1,0.82,0.14,4.71,1,133,,< 3 months
1.133.2 < 6 months,2,486,"Risk Ratio (IV, Random, 95% CI)","2.34 [0.56, 9.70]",Dose reduction versus dose maintenance,1,2.34,0.56,9.7,1,133,,< 6 months
1.134 Adverse effects ‐ specific: number of participants with insomnia (combined time points) Show forest plot,3,883,"Risk Ratio (IV, Random, 95% CI)","1.60 [0.55, 4.67]",Dose reduction versus dose maintenance,1,1.6,0.55,4.67,1,134,,Adverse effects ‐ specific: number of participants with insomnia (combined time points) Show forest plot
1.135 Adverse effects ‐ specific: number of participants with insomnia (separated time points) Show forest plot,3,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,135,,Adverse effects ‐ specific: number of participants with insomnia (separated time points) Show forest plot
1.135.1 < 3 months,1,20,"Risk Ratio (IV, Random, 95% CI)","0.41 [0.10, 1.75]",Dose reduction versus dose maintenance,1,0.41,0.1,1.75,1,135,,< 3 months
1.135.2 < 6 months,2,486,"Risk Ratio (IV, Random, 95% CI)","2.20 [0.52, 9.25]",Dose reduction versus dose maintenance,1,2.2,0.52,9.25,1,135,,< 6 months
1.135.3 < 1 year,1,397,"Risk Ratio (IV, Random, 95% CI)","0.99 [0.59, 1.67]",Dose reduction versus dose maintenance,1,0.99,0.59,1.67,1,135,,< 1 year
1.136 Adverse effects ‐ specific: number of participants with epileptic seizures Show forest plot,1,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,136,,Adverse effects ‐ specific: number of participants with epileptic seizures Show forest plot
1.136.1 < 3 months,1,20,"Risk Ratio (IV, Random, 95% CI)",Not estimable,Dose reduction versus dose maintenance,1,,,,1,136,,< 3 months
1.136.2 < 6 months,1,20,"Risk Ratio (IV, Random, 95% CI)",Not estimable,Dose reduction versus dose maintenance,1,,,,1,136,,< 6 months
1.137 Adverse effects ‐ mean change CGI‐SS (high = poor) Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,137,,Adverse effects ‐ mean change CGI‐SS (high = poor) Show forest plot
1.137.1 < 1 year,1,397,"Mean Difference (IV, Random, 95% CI)","0.05 [‐0.01, 0.11]",Dose reduction versus dose maintenance,1,0.05,-0.01,0.11,1,137,,< 1 year
1.138 Adverse effects ‐ mean change CSSRS (high = poor) Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,138,,Adverse effects ‐ mean change CSSRS (high = poor) Show forest plot
1.138.1 < 1 year,1,109,"Mean Difference (IV, Random, 95% CI)","‐0.10 [‐0.39, 0.19]",Dose reduction versus dose maintenance,1,-0.1,-0.39,0.19,1,138,,< 1 year
1.139 Adverse effects ‐ specific: number of participants with blurred vision Show forest plot,2,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,139,,Adverse effects ‐ specific: number of participants with blurred vision Show forest plot
1.139.1 < 3 months,1,20,"Risk Ratio (IV, Random, 95% CI)","2.50 [0.11, 54.87]",Dose reduction versus dose maintenance,1,2.5,0.11,54.87,1,139,,< 3 months
1.139.2 < 6 months,2,486,"Risk Ratio (IV, Random, 95% CI)","0.28 [0.01, 6.10]",Dose reduction versus dose maintenance,1,0.28,0.01,6.1,1,139,,< 6 months
1.140 Adverse effects ‐ specific: number of participants with constipation Show forest plot,2,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,140,,Adverse effects ‐ specific: number of participants with constipation Show forest plot
1.140.1 < 3 months,1,20,"Risk Ratio (IV, Random, 95% CI)","0.55 [0.11, 2.59]",Dose reduction versus dose maintenance,1,0.55,0.11,2.59,1,140,,< 3 months
1.140.2 < 6 months,2,486,"Risk Ratio (IV, Random, 95% CI)","0.35 [0.04, 3.07]",Dose reduction versus dose maintenance,1,0.35,0.04,3.07,1,140,,< 6 months
1.141 Adverse effects ‐ specific: number of participants with dry mouth Show forest plot,2,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,141,,Adverse effects ‐ specific: number of participants with dry mouth Show forest plot
1.141.1 < 3 months,1,20,"Risk Ratio (IV, Random, 95% CI)","4.17 [0.23, 77.11]",Dose reduction versus dose maintenance,1,4.17,0.23,77.11,1,141,,< 3 months
1.141.2 < 6 months,2,486,"Risk Ratio (IV, Random, 95% CI)","1.75 [0.36, 8.42]",Dose reduction versus dose maintenance,1,1.75,0.36,8.42,1,141,,< 6 months
1.142 Adverse effects ‐ specific: number of participants with hypersalivation Show forest plot,2,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,142,,Adverse effects ‐ specific: number of participants with hypersalivation Show forest plot
1.142.1 < 3 months,1,20,"Risk Ratio (IV, Random, 95% CI)","0.17 [0.01, 3.08]",Dose reduction versus dose maintenance,1,0.17,0.01,3.08,1,142,,< 3 months
1.142.2 < 6 months,2,486,"Risk Ratio (IV, Random, 95% CI)","0.99 [0.03, 36.96]",Dose reduction versus dose maintenance,1,0.99,0.03,36.96,1,142,,< 6 months
1.143 Adverse effects ‐ specific: number of participants with urinary retention Show forest plot,1,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,143,,Adverse effects ‐ specific: number of participants with urinary retention Show forest plot
1.143.1 < 3 months,1,20,"Risk Ratio (IV, Random, 95% CI)","0.17 [0.01, 3.08]",Dose reduction versus dose maintenance,1,0.17,0.01,3.08,1,143,,< 3 months
1.143.2 < 6 months,1,20,"Risk Ratio (IV, Random, 95% CI)","0.17 [0.01, 3.08]",Dose reduction versus dose maintenance,1,0.17,0.01,3.08,1,143,,< 6 months
1.144 Adverse effects ‐ specific: number of participants with leukopenia Show forest plot,1,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,144,,Adverse effects ‐ specific: number of participants with leukopenia Show forest plot
1.144.1 < 6 months,1,466,"Risk Ratio (IV, Random, 95% CI)","6.68 [0.27, 163.06]",Dose reduction versus dose maintenance,1,6.68,0.27,163.06,1,144,,< 6 months
1.145 Adverse effects ‐ specific: number of participants with neutropenia Show forest plot,1,466,"Risk Ratio (M‐H, Random, 95% CI)",Not estimable,Dose reduction versus dose maintenance,1,,,,1,145,,Adverse effects ‐ specific: number of participants with neutropenia Show forest plot
1.145.1 < 6 months,1,466,"Risk Ratio (M‐H, Random, 95% CI)",Not estimable,Dose reduction versus dose maintenance,1,,,,1,145,,< 6 months
1.146 Adverse effects ‐ specific: number of participants with thrombosis Show forest plot,1,,"Risk Ratio (M‐H, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,146,,Adverse effects ‐ specific: number of participants with thrombosis Show forest plot
1.146.1 < 6 months,1,466,"Risk Ratio (M‐H, Random, 95% CI)","0.74 [0.03, 18.12]",Dose reduction versus dose maintenance,1,0.74,0.03,18.12,1,146,,< 6 months
1.147 Adverse effect ‐ mortality: overall mortality (combined time points) Show forest plot,5,941,"Risk Ratio (IV, Random, 95% CI)","2.69 [0.48, 15.05]",Dose reduction versus dose maintenance,1,2.69,0.48,15.05,1,147,,Adverse effect ‐ mortality: overall mortality (combined time points) Show forest plot
1.148 Adverse effect ‐ mortality: overall mortality (separated time points) Show forest plot,5,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,148,,Adverse effect ‐ mortality: overall mortality (separated time points) Show forest plot
1.148.1 < 3 months,3,509,"Risk Ratio (IV, Random, 95% CI)",Not estimable,Dose reduction versus dose maintenance,1,,,,1,148,,< 3 months
1.148.2 < 6 months,3,509,"Risk Ratio (IV, Random, 95% CI)","3.25 [0.15, 72.36]",Dose reduction versus dose maintenance,1,3.25,0.15,72.36,1,148,,< 6 months
1.148.3 < 1 year,2,432,"Risk Ratio (IV, Random, 95% CI)","2.47 [0.31, 19.61]",Dose reduction versus dose maintenance,1,2.47,0.31,19.61,1,148,,< 1 year
1.149 Adverse effect ‐ mortality: mortality due to natural causes (combined time points) Show forest plot,4,906,"Risk Ratio (IV, Random, 95% CI)","1.51 [0.16, 14.02]",Dose reduction versus dose maintenance,1,1.51,0.16,14.02,1,149,,Adverse effect ‐ mortality: mortality due to natural causes (combined time points) Show forest plot
1.150 Adverse effect ‐ mortality: mortality due to natural causes (separated time points) Show forest plot,4,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,150,,Adverse effect ‐ mortality: mortality due to natural causes (separated time points) Show forest plot
1.150.1 < 3 months,3,509,"Risk Ratio (IV, Random, 95% CI)",Not estimable,Dose reduction versus dose maintenance,1,,,,1,150,,< 3 months
1.150.2 < 6 months,3,509,"Risk Ratio (IV, Random, 95% CI)","3.25 [0.15, 72.36]",Dose reduction versus dose maintenance,1,3.25,0.15,72.36,1,150,,< 6 months
1.150.3 < 1 year,1,397,"Risk Ratio (IV, Random, 95% CI)","0.67 [0.03, 16.44]",Dose reduction versus dose maintenance,1,0.67,0.03,16.44,1,150,,< 1 year
1.151 Adverse effect ‐ mortality: mortality due to suicide Show forest plot,5,,"Risk Ratio (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,151,,Adverse effect ‐ mortality: mortality due to suicide Show forest plot
1.151.1 < 3 months,4,606,"Risk Ratio (IV, Random, 95% CI)",Not estimable,Dose reduction versus dose maintenance,1,,,,1,151,,< 3 months
1.151.2 < 6 months,4,606,"Risk Ratio (IV, Random, 95% CI)",Not estimable,Dose reduction versus dose maintenance,1,,,,1,151,,< 6 months
1.151.3 < 1 year,1,397,"Risk Ratio (IV, Random, 95% CI)","6.07 [0.25, 147.95]",Dose reduction versus dose maintenance,1,6.07,0.25,147.95,1,151,,< 1 year
1.152 Cognition ‐ mean endpoint MCCB total (high = poor) Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,152,,Cognition ‐ mean endpoint MCCB total (high = poor) Show forest plot
1.152.1 < 3 months,1,75,"Mean Difference (IV, Random, 95% CI)","0.30 [‐5.26, 5.86]",Dose reduction versus dose maintenance,1,0.3,-5.26,5.86,1,152,,< 3 months
1.152.2 < 6 months,1,75,"Mean Difference (IV, Random, 95% CI)","‐6.00 [‐10.47, ‐1.53]",Dose reduction versus dose maintenance,1,-6.0,-10.47,-1.53,1,152,,< 6 months
1.152.3 < 1 year,1,75,"Mean Difference (IV, Random, 95% CI)","‐6.50 [‐11.44, ‐1.56]",Dose reduction versus dose maintenance,1,-6.5,-11.44,-1.56,1,152,,< 1 year
1.153 Cognition ‐ mean change RBANS (high = poor) Show forest plot,1,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,153,,Cognition ‐ mean change RBANS (high = poor) Show forest plot
1.153.1 < 1 year,1,61,"Mean Difference (IV, Random, 95% CI)","‐7.10 [‐10.90, ‐3.30]",Dose reduction versus dose maintenance,1,-7.1,-10.9,-3.3,1,153,,< 1 year
"1.154 Cognition ‐ mean endpoint/change overall cognition (MCCB, RBANS) (high = poor) (combined time points) Show forest plot",2,136,"Std. Mean Difference (IV, Random, 95% CI)","‐0.74 [‐1.08, ‐0.39]",Dose reduction versus dose maintenance,1,-0.74,-1.08,-0.39,1,154,,"Cognition ‐ mean endpoint/change overall cognition (MCCB, RBANS) (high = poor) (combined time points) Show forest plot"
1.154.1 < 1 year,2,136,"Std. Mean Difference (IV, Random, 95% CI)","‐0.74 [‐1.08, ‐0.39]",Dose reduction versus dose maintenance,1,-0.74,-1.08,-0.39,1,154,,< 1 year
"1.155 Cognition ‐ mean endpoint/change overall cognition (MCCB, RBANS) (high = poor) (separated time points) Show forest plot",2,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,155,,"Cognition ‐ mean endpoint/change overall cognition (MCCB, RBANS) (high = poor) (separated time points) Show forest plot"
1.155.1 < 3 months,1,75,"Mean Difference (IV, Random, 95% CI)","0.30 [‐5.26, 5.86]",Dose reduction versus dose maintenance,1,0.3,-5.26,5.86,1,155,,< 3 months
1.155.2 < 6 months,1,75,"Mean Difference (IV, Random, 95% CI)","‐6.00 [‐10.47, ‐1.53]",Dose reduction versus dose maintenance,1,-6.0,-10.47,-1.53,1,155,,< 6 months
1.155.3 < 1 year,2,136,"Mean Difference (IV, Random, 95% CI)","‐6.88 [‐9.89, ‐3.86]",Dose reduction versus dose maintenance,1,-6.88,-9.89,-3.86,1,155,,< 1 year
1.156 Medication – mean antipsychotic dose at endpoint (olanzapine equivalents mg/d) (combined time points) Show forest plot,15,,"Mean Difference (IV, Random, 95% CI)",Totals not selected,Dose reduction versus dose maintenance,1,,,,1,156,,Medication – mean antipsychotic dose at endpoint (olanzapine equivalents mg/d) (combined time points) Show forest plot
1.157 Medication – mean antipsychotic dose at endpoint (olanzapine equivalents mg/d) (separated time points) Show forest plot,17,,"Mean Difference (IV, Random, 95% CI)",Subtotals only,Dose reduction versus dose maintenance,1,,,,1,157,,Medication – mean antipsychotic dose at endpoint (olanzapine equivalents mg/d) (separated time points) Show forest plot
1.157.1 Baseline,13,1490,"Mean Difference (IV, Random, 95% CI)","0.02 [‐0.37, 0.41]",Dose reduction versus dose maintenance,1,0.02,-0.37,0.41,1,157,,Baseline
1.157.2 < 3 months,4,213,"Mean Difference (IV, Random, 95% CI)","‐7.71 [‐13.53, ‐1.89]",Dose reduction versus dose maintenance,1,-7.71,-13.53,-1.89,1,157,,< 3 months
1.157.3 < 6 months,5,810,"Mean Difference (IV, Random, 95% CI)","‐10.79 [‐18.78, ‐2.81]",Dose reduction versus dose maintenance,1,-10.79,-18.78,-2.81,1,157,,< 6 months
1.157.4 < 1 year,10,1308,"Mean Difference (IV, Random, 95% CI)","‐8.72 [‐11.52, ‐5.92]",Dose reduction versus dose maintenance,1,-8.72,-11.52,-5.92,1,157,,< 1 year
1.157.5 > 1 year,2,229,"Mean Difference (IV, Random, 95% CI)","‐7.37 [‐18.72, 3.99]",Dose reduction versus dose maintenance,1,-7.37,-18.72,3.99,1,157,,> 1 year
2.1 Excluding studies at high risk of bias (Remington 2011 and Rouillon 2008 excluded) Show forest plot,7,1301,"Risk Ratio (IV, Random, 95% CI)","1.66 [0.81, 3.39]",Sensitivity analyses ‐ service use ‐ rehospitalisation,2,1.66,0.81,3.39,2,1,,Excluding studies at high risk of bias (Remington 2011 and Rouillon 2008 excluded) Show forest plot
2.1.1 Combined time points,7,1301,"Risk Ratio (IV, Random, 95% CI)","1.66 [0.81, 3.39]",Sensitivity analyses ‐ service use ‐ rehospitalisation,2,1.66,0.81,3.39,2,1,,Combined time points
2.2 Fixed‐effect Show forest plot,9,1433,"Risk Ratio (IV, Fixed, 95% CI)","1.46 [1.08, 1.98]",Sensitivity analyses ‐ service use ‐ rehospitalisation,2,1.46,1.08,1.98,2,2,,Fixed‐effect Show forest plot
2.2.1 Combined time points,9,1433,"Risk Ratio (IV, Fixed, 95% CI)","1.46 [1.08, 1.98]",Sensitivity analyses ‐ service use ‐ rehospitalisation,2,1.46,1.08,1.98,2,2,,Combined time points
3.1 Excluding studies at overall high risk of bias (Rouillon 2008 excluded) Show forest plot,9,1243,"Risk Ratio (IV, Random, 95% CI)","2.21 [1.38, 3.53]",Sensitivity analyses ‐ adverse effects ‐ leaving the study early due to adverse effects ‐ overall tolerability,3,2.21,1.38,3.53,3,1,,Excluding studies at overall high risk of bias (Rouillon 2008 excluded) Show forest plot
3.1.1 Combined time points,9,1243,"Risk Ratio (IV, Random, 95% CI)","2.21 [1.38, 3.53]",Sensitivity analyses ‐ adverse effects ‐ leaving the study early due to adverse effects ‐ overall tolerability,3,2.21,1.38,3.53,3,1,,Combined time points
3.2 Excluding studies that did not use operationalised criteria to diagnose schizophrenia (Volavka 2000 excluded) Show forest plot,9,1317,"Risk Ratio (IV, Random, 95% CI)","2.20 [1.37, 3.52]",Sensitivity analyses ‐ adverse effects ‐ leaving the study early due to adverse effects ‐ overall tolerability,3,2.2,1.37,3.52,3,2,,Excluding studies that did not use operationalised criteria to diagnose schizophrenia (Volavka 2000 excluded) Show forest plot
3.2.1 Combined time points,9,1317,"Risk Ratio (IV, Random, 95% CI)","2.20 [1.37, 3.52]",Sensitivity analyses ‐ adverse effects ‐ leaving the study early due to adverse effects ‐ overall tolerability,3,2.2,1.37,3.52,3,2,,Combined time points
3.3 Excluding studies conducted in mainland China (Zhou 2018 excluded) Show forest plot,9,1265,"Risk Ratio (IV, Random, 95% CI)","2.20 [1.39, 3.49]",Sensitivity analyses ‐ adverse effects ‐ leaving the study early due to adverse effects ‐ overall tolerability,3,2.2,1.39,3.49,3,3,,Excluding studies conducted in mainland China (Zhou 2018 excluded) Show forest plot
3.3.1 Combined time points,9,1265,"Risk Ratio (IV, Random, 95% CI)","2.20 [1.39, 3.49]",Sensitivity analyses ‐ adverse effects ‐ leaving the study early due to adverse effects ‐ overall tolerability,3,2.2,1.39,3.49,3,3,,Combined time points
3.4 Fixed‐effect Show forest plot,10,1340,"Risk Ratio (IV, Fixed, 95% CI)","2.20 [1.39, 3.49]",Sensitivity analyses ‐ adverse effects ‐ leaving the study early due to adverse effects ‐ overall tolerability,3,2.2,1.39,3.49,3,4,,Fixed‐effect Show forest plot
3.4.1 Combined time points,10,1340,"Risk Ratio (IV, Fixed, 95% CI)","2.20 [1.39, 3.49]",Sensitivity analyses ‐ adverse effects ‐ leaving the study early due to adverse effects ‐ overall tolerability,3,2.2,1.39,3.49,3,4,,Combined time points
4.1 Speed of dose reduction (abrupt vs gradual) Show forest plot,20,2481,"Risk Ratio (IV, Random, 95% CI)","2.16 [1.52, 3.06]",Subgroup analysis ‐ global state ‐ number of participants with relapse/exacerbations of psychosis (post hoc),4,2.16,1.52,3.06,4,1,,Speed of dose reduction (abrupt vs gradual) Show forest plot
4.1.1 Abrupt,11,1660,"Risk Ratio (IV, Random, 95% CI)","2.22 [1.41, 3.51]",Subgroup analysis ‐ global state ‐ number of participants with relapse/exacerbations of psychosis (post hoc),4,2.22,1.41,3.51,4,1,,Abrupt
4.1.2 Gradual,9,821,"Risk Ratio (IV, Random, 95% CI)","2.10 [1.26, 3.49]",Subgroup analysis ‐ global state ‐ number of participants with relapse/exacerbations of psychosis (post hoc),4,2.1,1.26,3.49,4,1,,Gradual
